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SUMMARY 
The dissertation entitled "Photochemical Studies on Photosensitizing Drugs" 
describes photochemical studies on photosensitizing drug molecules with emphasis on 
the isolation and identification of the possible degradation products and to investigate 
the mechanistic pathways of photosensitive drug molecules in the presence of 
artificial light. The dissertation is divided in two chapters which include: 
Chapter 1 "General Introduction" to the subject and the aim of this work is given in 
this chapter. The basis of drug photochemistry is reviewed and scope and neu 
perspectives for this research, in terms of photochemistry of photosensitizing drugs, 
are also presented. 
Chapter 2 describes our research work, where all the details of methods employed for 
in vitro photochemical studies on antipsychotic photosensitizing drugs 
triflupromazine (1) and quetiapine (6) are given along with the photoph) sical 
parameters obtained . In the first part of chapter 2, we studied electron-transfer 
mechanism in the photodegradation of phototoxic drug triflupromazine (1). 
Photoproducts were characterized on the basis of their IR, UV, ' H - N M R , ' ^ C - N M R 
and Mass spectral studies. When TPZ (1) was irradiated with a high-pressure mercury 
lamp under anaerobic conditions in the presence of electron-donor N, N-
dimethylaniline (DMA), it afforded photoproducts Dimethyl-(3-phenothiazin-10-yl-
propyl)-amine (2) and [3-(2-Methoxy-phenothiazin-10-yl)-propyl]-dimethyl-amine 
(3). When a similar irradiation was carried out in the presence of an electron-acceptor 
1, 4-dicyanobenzene (DCB), it afforded two photoproducts 3-(2-Trifluoromethy/-
phenothiazin-10-yl)-propionaldehyde (4) and Methyl-[2-(2-trifluoromethyl-
phenothiazin-10-yl)-ethyl]-amine (5). The formation of photoproducts was explained 
through the photoinduced electron transfer mechanism. 
In the second part of chapter 2, we studied electron-transfer mechanism in the photo 
degradation of phototoxic drug quetiapine (6). Photoproducts were characterized on 
the basis of their IR, UV, ' H - N M R , ' ^ C - N M R and Mass spectral studies. When QTP 
(6) was irradiated in the presence of electron-donor molecule (DMA), it afforded one 
major photoproduct 2-{2-[4-(10, 11-Dihydro-dibenzo [b, J] [1, 4] thiazepin-U-yl)-
piperazin-I -ylj-ethoxy} ethanol (7). When a similar irradiation was carried out in the 
presence of an electron-acceptor 1, 4-dicyanobenzene (DCB), it afforded 
photoproduct y-Z)/6e«zo [b, f] [I, 4] thiazepin-11-yl-N'-ethyl-ethane-1, 2-diamine 
(8). The formation of photoproducts was explained through the photoinduced electron 
transfer mechanism. The observed photophysical and photochemical properties of 
these photosensitizing drugs and their proposed mechanism of photodegradation 
through photoinduced electron transfer, hopefully may have implications to their 
mechanism of photosensitization. 
N. ^ N O 
N - HO 
Triflupromazine Quetiapine 
(1) (6) 
Chapter 1 
General Introduction 
Pagel 
A general introduction to the subject area of research and the background of the 
present research work is presented in this chapter. The role of photochemistry in 
photobiology is defined and aspects of drug photochemistry, especially 
photosensitizing drugs, are presented with the latest literature in the area. This 
includes the scope and new perspectives for this research, in terms of photochemistry 
and the mechanisms of photodegradation and photosensitization. Special emphasis is 
on chemistry of photoinduced electron transfer mechanism, which also entails the aim 
of this work. 
Lisht is a ubiquitous element of our environment with a tremendous impact on life. 
Without light, life, as we know it would not exist both, the beneficial and the harmful 
effects of light are well recognized and there is growing awareness of the influence of 
light (both beneficial and harmflil) on living organisms'. Recognition of the 
importance of light in biology has led to the development of the science of 
photobiology: the study of the myriad effects of light on life. Photobiology studies the 
interaction of light with living organisms, and the application encompasses a number 
of areas including environmental photobiology, photomedicine and UV photobiology, 
which is the study of the effects of ultraviolet radiation on plants, animals and 
humans . 
Oxvsen is also a ubiquitous element of our environment with a tremendous impact on 
animal and plant life. Molecular oxygen is a unique and fascinating molecule that is 
integral to many processes^ that occur on earth. It plays a key role in the maintenance 
of life, and in mechanisms by which life is extinguished and materials destroyed. 
Oxygen is not only fundamentally essential for energy metabolism and respiration, 
but it has been implicated in many diseases and degenerative conditions. The parallel 
Page 2 
role of oxygen as a destructive'' (toxic) agent for living tissues has been discovered 
much more recently. Since oxygen is ubiquitous and efficiently quenches 
electronically excited states, 'O2 is likely to be formed following irradiation in 
countless situations and involved in various chemical and biological processes as well 
as in several disease processes. Reactive intermediates include singlet oxygen ( O2. a 
metastable excited state of molecular oxygen), superoxide ion, and other reactive 
oxygen species: 'O2, O2", OH •, HO2' , RO2', despite its acknowledged^ significance, 
the study of oxygen and oxygen-dependent processes continues to present challenging 
problems. 
Xenobiotics are any chemical compounds that are found in a living organism, but 
which are foreign to that organism, in the sense that it does not normally produce the 
compound^ or consume it as part of its diet. For example, in humans, most drugs are 
considered xenobiotics, since we don't produce them naturally, or consume them in 
our normal diets. Xenobiotics are extensively used in, for example, drugs, cosmetics. 
food and agricultural chemicals. The human body is exposed to wide arrav of 
xenobiotics in one's lifetime, from food components to environmental toxins to 
pharmaceuticals and pesticides. 
A combination of light and xenobiotics, in the presence or absence of oxygen, often 
produces an undesirably menacing situation in biological systems. Although 
xenobiotics are very useful and almost indispensable, many of them are 
photosensitizer. They can produce adverse biological^ (phototoxic) effects due to 
ubiquitous light and oxygen and the resulting photochemistry. 
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The interest in human photobiology is currently growing for a number of reasons. 
First, sunlight is beneficial to health but overexposure as a result of increased outdoor 
activities can cause skin cancer^ and accelerated aging of vital organ'°. Further, 
artificial light sources, such as fluorescent tubes and the new and increasingly popular 
high intensity lamps are now used worldwide for lighting of large public shopping 
areas, factory-buildings, offices and private houses. As a large part of population 
spends much of its time in these artificially illuminated places, in which light intensity 
and spectral distribution differ considerably from those found outdoors, there is a 
concern about the consequences for human health. Thus, it is not only because of 
lamps used for sunbathing that the role of artificial light in human health and diseases 
has begun to receive serious attention". 
Second, spectral distribution and intensity of daylight will change if ozone layer in the 
stratosphere, which filters out much of the short wavelength UV radiation'^, is 
deteriorated by gases from, e.g., spray cans and supersonic aircraft. A change in the 
spectral distribution and intensity of daylight is expected to have serious 
consequences for human health. 
Third, xenobiotics (drugs, cosmetics, pesticides etc.) can also interfere in the balance 
between light and the human body. The effects may be beneficial and thus the 
combination of light and drug can be used as therapeutics. Often however, the effects 
are unintended and uncontrolled and damage of organ functions occurs. 
Photosensitization is among the new trends in photobiology and is the process by 
which sun or light induced abnormal reactions are mediated by exogenous chemicals 
in biological systems. A photosensitizins asent is a compound whose chemical 
configuration endows it with the ability to absorb UV radiation or visible radiation' 
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and to undergo a light-dependent photochemical reaction resulting in the generation 
of highly reactive species, relatively metastable (long-lived) intermediate states (e.g.. 
triplet state, free radical state, and ions) that cause chemical and functional 
modification in other molecules of biological systems . 
Photobiologists working with ultraviolet radiation are concerned with identifying the 
photochemical changes that are produced in living tissue by the absorption of 
ultraviolet light and determining the biochemical and physiological responses of cells 
to this damage. Today the major challenges to this topic include the elucidation of 
photochemical reactions involved in photobiology at the molecular level, where 
organic photochemistry has a significant role to play. 
Since all photobiological responses to light are consequence of photochemical 
changes produced in biological systems, it is important to stimulate more chemists to 
work on the molecular basis of photobiological problems. In addition to identifying 
photoproducts, chemists can contribute to the understanding of photobiological 
phenomena by studying details of the photochemical steps'^ Once photochemical 
mechanism is known it is usually possible to learn how to modify the photochemistry, 
which is quite useful for relating molecular events to photobiological'^ phenomena. 
The number and variety of phototoxic compounds are large. Furthermore, for most 
phototoxic xenobiotics a correlation between structure and photoreactivity is not 
easily found. It is obvious that, in general, there must be a relationship between 
photochemical behavior and phototoxicity. 
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// is therefore highly desirable to put on record the photoreactivity of all common 
chemicals that may be exposed to sunlight. In the present study emphasis has been 
placed on the photochemistry of photosensitizing drugs. 
Druss, now a day, have become very essential xenobiotics for human life. Several 
families of drugs have attained therapeutic importance because they exhibit anti-
inflammatory, analgesic, antipyretic, diuretic, and also antibacterial properties. A drug 
substance or drug product can be exposed to natural or artificial light during 
production, storage, administration and their use. The treatment of disease requires the 
use of either systemic or topical medication during certain period of time. Frequently 
the treatment coincides with exposure to electromagnetic radiation, coming from 
different types of sources (sunlight in works made outdoor and intense artificial 
radiation used in specific works etc.). As many drug substances and some formulation 
excipient (e.g., pharmacologically inactive ingredients in pharmaceutical 
preparations) absorb optical radiation in the UV (290-400 nm) or visible (400-800 
nm) part of the spectrum, they have the potential of being photoreactive in vitro 
and/or in v/vo'^. The photoreactivity of a drug substance may lead to drug photo-
instability and drug photodegradation: rationalized as drug photochemistry. 
The drug initially absorbs energy from UVAAJVB light, and then the photon energy 
excites an absorbing molecule into the singlet state. The energy is generally dissipated 
via radiative processes (fluorescence, phosphorescence), or radiationless processes 
generating kinetic energy (heat), and then the molecule returns into the single ground 
state. It is also possible that the excited singlet molecule undergoes intersystem 
crossing into the more long-lived triplet state, and energy transfer from a donor (D ) 
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to an acceptor molecule (A*) can occur when the two molecules enter into close 
contact during collision. 
The photochemistry of drugs does not differ, in general terms, from that of the other 
molecules, and can therefore be rationalized (and can be roughly predicted) according 
to the same generalizations that are useful in organic photochemistry. The basic 
photophysical and photochemical processes of drugs are described here. 
Consider first the photophysical processes, which can be best described by an energy-
level diagram (Fig. 1.1) and Eq. 1.1-1.7. Any UVR- or visible light-induced process 
begins with the excitation of drug molecules or sensitizers, from their ground state 
(Do) to reactive excited states, by absorption of photons of certain wavelengths. As 
shown in Eq. 1.1, upon absorption of radiation, the drug molecule. Do, in the ground 
state in which the valence electrons are paired or anti-parallel (a spin singlet state) is 
raised to a higher energy level, as a valence electron moves to the first available outer 
shell corresponding to the first excited singlet state, ' D (the electron spins remain anti-
parallel). When the absorption spectrum shows more than one absorption band, this 
indicates a corresponding number of excited states that can be reached by irradiation 
with the appropriate excitation wavelength. The molecule cannot persist in an excited 
state indefinitely because it represents a less stable situation with respect to the 
ground state. 
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Fig. 1.1: Energy levels of molecules showing transitions involving fluorescence, 
phosphorescence, internal conversion, and intersystem crossing. 
A variety of competing physical processes involves energy dissipation and result in 
deactivation of the excited states. The energy dissipation may be via internal 
conversion (IC) (Eq. 1.2), which is a nonradiative transition between states of like 
multiplicity, or via photon emission (fluorescence) resulting in return to Do (Eq. 1.3). 
Even if excitation occurs to an excited state higher than the first, IC will always bring 
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the molecule to the ^D level (within a picosecond) before fluorescence occurs. Thus, 
the fluorescence emission wavelength is the same, irrespective of the irradiating 
wavelength. Any excess energy within a particular electronic state is dissipated as 
heat by collision with neighboring molecules-referred to as vibrational relaxation 
(VR). 
Because the lifetime of the excited singlet state of a molecule is generally of the order 
of nanoseconds (but up to microseconds for rigid molecular structures), the possibility 
of interaction with neighboring molecules leading to chemical change is limited at this 
stage. However, in the excited singlet state, the ionization potential of the molecule is 
reduced; the excited electron is more easily removed than it is from the ground state 
molecule, but requires an appropriate acceptor to be present. This process oi' 
photoionization (Eq.1.4) is also more likely to occur if higher energy UVR is used 
(i.e., wavelengths less than 300 nm) and if the molecule is in the anionic state. 
Alternatively, intersystem crossing (ISC) may occur from the excited singlet state to a 
metastable excited triplet state ^D (electron spins parallel) (Eq. 1.5). Despite the low 
probability in general for transfer between states of differing multiplicity, ISC occurs 
with relatively high efficiency for most photochemically active molecules. Because of 
its longer lifetime (microseconds to seconds, or even longer), the excited triplet state 
may diffuse a significant distance in fluid media and therefore has a much higher 
probability of interaction with other molecules. If no interaction occurs, it decays back 
to the ground state by another ISC event (Eq. 1.6), or by phosphorescence emission 
(Eq. 1.7). 
The excited molecule has a different electronic character compared to the ground state 
and is often able to form a complex (called an exciplex) with another species 
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(designated as Q), i.e., the complex is D*Q. The symbol Q is used because, in effect, 
the interacting molecule is a quencher of the native fluorescence of D. Sometimes, at 
a high concentration of the absorbing molecule, this occurs with the ground state (in 
which case the D*D species formed is called an excimer). The formation of the 
exciplex or excimer is observed as a shift in the fluorescence emission to longer 
wavelength-the difference in energy between exciplex and normal fluorescence 
reflecting the stability of the exciplex. No exciplex formation has been reported in the 
literature to involve drug molecules, but this remains a possibility in concentrated 
solution or perhaps in solid-state mixtures. The consequences of exciplex formation 
are a radiative or nonradiative return to the ground state without chemical change, or 
electron transfer leading to chemical reaction of the drug, the quencher, or both'^ 
The electronically excited state of a molecule will act as a more powerful electron 
donor or acceptor than the ground state. The reactions that can occur are, respectively, 
oxidative or reductive quenching: 
Oxidative quenching: D*+ Q 
Reductive quenching: D*Q 
The exact nature of the reaction (oxidative vs. reductive) will depend on the redox 
properties of D* and Q. The electron transfer process is a special case of exciplex 
formation favored in the strongly polar solvents, such as water. The involvement of an 
exciplex in a photochemical reaction is generally established by studying the effects 
of known exciplex quenchers such as amines on the exciplex fluorescence and the 
product formation. The heavy atom effect, due to the presence of substituent's such as 
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Q 
uu 
• - • + 
- ^ D + Q 
.+ • -
-^ D + Q (1.8) 
(1.9) 
bromine or iodine intra- or intermolecularly, causes an exciplex to move to the triplet 
state preferentially, with a quenching of fluorescence. 
Action of light in chemical transformations can be classified in two main groups: 
Direct photochemical reactions: molecules which absorb light are that which are 
transformed. Photosensitized reactions: the light is absorbed by a different molecule 
to that we wish to transform. In the second case the sensitizer which absorbs a photon 
may react in two ways: electron transfer or energy transfer. 
Irradiation has two main effects on drugs: The first is the influence of light exposure 
on the stability of the drug substances and drug formulations'^ leading to the drug 
photodegradation. The second aspect of drug-light interactions may result in the 
formation of free radicals and/or reactive oxygen species (e.g., singlet oxygen. 
superoxide, hydroxyl radical, peroxides, peroxy radicals, etc.) and also reaction with 
biological molecules, resulting in drug-induced photosensitivity and the 
photobiological effects . The photoinduced reactions might or might not be identical 
in vitro and in vivo, depending on the environment and chemistry of the absorbing 
species. It is commonly assumed that phototoxicity of drugs remains restricted to the 
organs exposed to light, namely the skin and eyes. However, there are natural 
photobiological processes in man by which the eventual effects occurs in a part of the 
body far from the sunlight exposed organ in which photoexcitation of an endogenous 
compound took place^'. 
Drugs belonging to various pharmaceutical classes are photosensitizing: antibiotics. 
non-steroidal anti-inflammatory drugs, diuretics, antimitotic drugs, psychiatric drugs. 
amiodarone, calcium channel blockers and fibric acid derivatives. Photosensitivity 
caused by drug reactions may be defined as unwanted pharmacological effects 
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produced when the skin is sensitized by topical or systemic medications, or both, and 
exposed to UV rays, either artificially or naturally. Such peculiar and often distressing 
photobiological reactions are commonly considered to be the undesirable adverse 
effects of commonly administered drugs. The majority of drugs that have been 
reported to be associated with photosensitivity absorb in the (UVA, 320 to 400 nm) or 
(UVB, 290 to 320 nm) UVA. Many sensitizing drugs are knovm to exert 
photoinduced adverse biological effects, such as phototoxicity, photoallergy, 
photomutagenesis and photocarcinogenesis^^. However, the number of 
photosensitization disorders attributed to these drugs is high^^. In general, the 
generation of an adverse photosensitivity response can be postulated to involve one or 
more of the pathways as shown in Fig. 1.2. This general scheme indicates possible 
reaction processes by which a photosensitizing drug may give rise to adverse 
photobiological effects. 
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Fig. 1.2: Schematic representation of possible pathways for phototoxic responses 
induced by photosensitive drugs. 
The topic of drug photochemistry has always received a considerable amount of 
attention but recently the interest has markedly increased due to the awareness among 
the scientific commimity of an increase in the UV portion of the sun spectrum 
reaching the earth '^*. Currently, the photostability of the drug is a matter of great 
concern, because light-induced decomposition can impair drug potency and Induce 
photosensitivity effects. The photochemistry of photosensitizing drugs is receiving 
much recent attraction as the number of drugs that are found to be photochemically 
unstable and are able to induce phototoxic side-effects is steadily increasing^l As this 
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property is shared by a wide variety of drugs with diverse pharmacological activities 
and different structural formulae, it has been difficult to establish satisfactory 
structure-activity relationships. Hence, within the context, the molecular mechanisms 
of degradation of photosensitizing drugs and their adverse photosensitive reactions is 
of great concern. A detailed understanding of these molecular mechanisms is essential 
to anticipate and prevent the appearance of phototoxic or photoallergic side- effect. 
This field requires a systematic and careful study on the photochemical behaviour of 
the drugs, which includes isolation of photoproducts, identification of intervening 
excited states and reactive intermediates, photoreaction with biological targets, where 
a photochemist can play a significant role. Over the past decade there has been a 
considerable amount of research toward understanding both the unimolecular 
deactivation pathway of photoexcited pharmaceutical product and their 
photosensitizing capability. The majority of the work done in the last few years 
concerning the mechanisms of both drug photodegradation and photosensitization has 
appeared in recent reviews^^"^'. 
All photosensitizers contain a chromophore whereby absorption of light leads to 
generation of an excited state. Photosensitized reactions occur by a process in which 
light activation of a chromophore induces chemical changes in another molecule than 
the chromophore itself The initial step of this reaction is the absorption of a photon 
by the photosensitizer (Ph), leading to the generation of an excited state (^Ph*). Many 
photosensitization reactions proceed through a triplet state. So, a favoured intersystem 
crossing pathway must be expected effective for photosensitization. Apart from the 
monomolecular pathway of deactivation for the excited photosensitizer (fluorescence, 
phosphorescence emission or non radiative deactivation), the fate of the 
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photosensitizers in the excited state may be very different depending on the solvent. 
photosensitizer concentration, energy absorbed by the photosensitizer " , type oi 
substrate, proximity of substrate and photosensitizer, aerobic or anaerobic conditions. 
pH etc. 
In photosensitized reactions the sensitizer which absorbs a photon may react in two 
ways: electron transfer or energy transfer. If the photo activated photosensitizer 
produces changes that involve oxygen, the process is referred to as photodynamic 
action. The photosensitizer here reacts with biological system through oxygen by two 
mechanisms: electron transfer (Type I) or energy transfer (Type II). Otherwise in the 
absence of oxygen photosensitizer may react directly with the biological system 
through the transfer of electrons or protons (Type I), and exert photosensitization 
effect, whereby, drug may undergo photoinduced fragmentation reactions " . Thus. 
photosensitization reactions are classified into two categories, oxygen dependent and 
TO 
oxygen-independent (anoxic) processes . 
The literature reports significant mechanistic variations for different photosensitizing 
drugs. The differences found in the phototoxic mechanisms of different 
photosensitizing drugs appears linked, in principle, to structural features which may 
differ from one molecule to other, even in the molecules pertaining to the same 
chemical group. Thus, it has been rationalized that four pathways are usually 
considered available for the excited photosensitizing drug to exert phototoxic effects 
on some target in the biological substrate. These are: singlet oxygen formation, radical 
formation, covalent photobinding and production of photoproducts in decomposition 
reaction^'"^". 
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It is obvious from literature that many photosensitization reactions may be explained 
on the basis of the mechanism Type I (radical formation through electron transfer) or 
Type II (singlet oxygen formation through energy transfer). Frequently Type I and 
Type II reactions occur simultaneously and it is difficult to separate the effects 
corresponding to each Type. All these possible mechanistic courses have been 
illustrated in Fig. 1.3 and Eq. 2.0-3.2. 
Oxidized 
, 
products 
1 
S 
'O2 
1 ^Ph -•--
C^ h 
Type II 
P^h -
, 
hv 
Type I , / 
Oxidized products 
^0, 
I 
•+ ._ • - •+ 
S +Ph/ S+Ph 
/ 
s 
»ph 
Fig. 1.3: Diagram of photosensitizations mechanisms occurring after absorption of 
photons by a photo sensitizer. 
First of all, an energy transfer (Eq. 2.0) from excited triplet photosensitizer ( Ph ) to 
the oxygen molecule could produce excited singlet oxygen which might, in turn, 
participate in a lipid- and protein- membrane oxidation or induce DNA damage. 
^Ph' ^O, Ph + 'O, 'O9 + S (2.0) 
Second, an electron or hydrogen transfer could lead to the formation of free-radical 
species producing a direct attack on the bio-molecules (Eq. 2.1-2.4). In this type of 
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photochemical reaction, the exited triplet state of the photosensitizer ( Ph*) interacts 
directly with the substrate molecule (S) and leads to the formation of pairs of neutral 
radicals or radical ions following an electron or hydrogen transfer as shown in the Eq. 
2.1 & 2.2. Most biological substrates undergo an oxidation: (Eq. 2.1). 
^Ph* + S *- Pli + S ^ (2.1) 
3ph' + S ^ Ph^ + s"~ (2.2) 
Both the excited photosensitiser i^Ph*) and the ground state substrate (S) can act as a 
hydrogen donor (Eqs. 2.3-2.4). 
3phH* + S ^ Ph' + SH* (2.3) 
3ph* + SH *- PhH* + S* (2.4) 
In the presence of oxygen, for example, oxidized forms of both sensitiser and 
substrate (S) readily react with O2 to give peroxyl radicals, thus initiating a radical 
chain auto-oxidation (Eqs. 2.5-2.6) or the very reactive hydroxyl radical a known 
intermediate in the oxidative damage of DNA and other bio-molecules. 
s 
soo* 
1 0 
-t VJ2 
+ SH • 
soo' 
S* + SOOH 
(2.5) 
(2.6) 
This latter pathway corresponds to successive reactions are that the semi reduced 
forms of the photosensitizer or of the substrate also interact efficiently with oxygen 
and the electron transfer which takes place between the reactants, generates 
superoxide radical anion (Eqs.2.7). 
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S + O2 
Ph~ + O2 
S + O2 
Ph + O'-
(2.7) 
Any reaction that generates O2" will also produce hydroperoxide H2O2 by 
spontaneous dismutation (Eq. 2.8) to form hydroxyl radical or one-electron reduction 
(Eq. 2.9). 
O2 + O, + 2H + 
+ O2 + 2H + e 
O2 + H2O2 
H2O2 
(2.8) 
(2.9) 
Hydroperoxide is a moderate oxidant, but when it accumulates, it can react with 
superoxide radical anions (Eq. 3.0) or undergo ferrous ion catalyzed reduction to give 
rise to an extremely reactive hydroxyl radical (Haber-Weiss reaction) (Eqs. 3.1-3.2). 
Generation of the radical takes place involving either the photosensitizer or the target 
bio-molecule. 
O7 + H,0 2'-^2 
3+ O7 + Fe 
H2O2 + Fe 
O2 + OH + OH (3.0) 
O2 + Fe^ 
OH + OH + Fe^^ 
(3.1) 
(3.2 
. Haber-Weiss 
reaction 
Many photosensitization reactions may be explained on the basis of the mechanism 
Type-I or Type-II, but are also possible additional pathways. Thus, a covalent 
photobinding (Eq. 3.3) between photosensitiser and one particular macromolecule 
could take place inducing cell damage as well. 
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3ph* + S »- Ph—S (3.3) 
Finally, the photosensitiser could undergo a decomposition (probably via homolytic 
process) shown in Eq. 3.4-3.5, so that the resulting photoproducts (PP) can act either 
as toxins or as new photosensitisers. 
^Ph* + (Oxi/red) • Ph* • PP ^=> PP-S (3.4) 
PP + hv • PP* =^ PP* + S (3.5) 
It is important to note that chemically there are two main types of photosensitization 
mechanisms caused by excited sensitizer: Type I (direct radical mediated-reactions) 
and Type II (singlet oxygen-mediated reactions). Many important photosensitization 
reactions are Type I processes, and the study of the biological effects of radical 
produced via electron transfer process in photosensitization reactions is an important 
area of research in modem photobiology'*'"^^. An Electron Transfer Mechanism in 
photosenstization by the some important class of drugs including, flouroquinolone. 
NSAID, Phenothiazine, 1-4-dihydropyridin, vasoregulator have been highlighted in 
recent publication. Photo-initiated electron transfer reactions in drugs receiving 
considerable attention recently from a more fundamental photochemical standpoint 
and many reactions such as cycloadditions, cycloreversions, oxygenations and 
photodegradation of drugs have been documented. The electron transfer mechanism 
of drug photodegradation and photosensitization is also the subject present work, and 
hence the basic photoinduced electron transfer (PET) chemistry is described in the 
following pages'*''"'*'*. 
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Chemistry of photoinduced electron transfer 
Photoinduced electron transfer (PET) reactions are one of the most fundamental 
processes in chemistry and biology, as it is underlying many photochemical and 
photobiological reactions. Nature frequently invokes electron transfer in a variety of 
enzymatic processes such as oxidative phosphorylation, the DNA-photolyase reaction 
and the primary life sustaining process on earth, photosynthesis, is initiated by PET. 
Photoinduced electron transfer processes have widespread application in 
semiconductor photocatalysis, imaging systems, such as silver halide photography, 
spectral sensitization and xerography, and in preparative organic synthesis. In 
chemistry PET is important because it has uncovered simple pathways for the 
synthesis of novel organic molecules. Products formed by PET could be very reactive 
and can undergo versatile chemical reactions of mechanistic and synthetic 
significance'*^"^*. 
Photoinduced electron transfer is the branch of photochemistry that exploits the 
ability of certain photoexcited molecules to act as strong oxidizing or reducing 
species, and induce a permanent chemical change in a ground state molecule through 
an electron transfer mechanism. After being oxidized or reduced by a photosensitizer, 
an organic substrate is transformed into a reactive intermediate that is capable of 
undergoing a variety of reactions. Photoinduced electron-transfer reaction plays 
important roles in many photosensitization phenomena and in drug photosensitization 
it is receiving considerable attention in recent years from a more fundamental 
photochemical standpoint, and many reactions such as cycloadditions'*^, 
cycloreversions, oxygenations and photodegradation of drugs have been documented. 
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Understanding and control of PET reactions comprise one of the broadest and 
flourishing areas of research today. 
The rationalization of photoinduced electron transfer reactions in photosensitizaiion 
requires an understanding of the principles of photochemistry and underlying theor\ 
of electron transfer. Electrons are not bound equally strongly in all atoms and 
molecules, as some have greater affinity for the electron than others. Electron rich 
systems which can readily give up an electron are called Donors (D). 
Correspondingly, electron deficient units which have the ability to pick up an electron 
are referred to as Acceptors (A). When systems with varying capacity to hold the 
electron are brought together, there is a likelihood of an electron hopping from the 
weakly bound to the strongly bound unit. Thus electron transfer is possible when D 
and A type molecules are allowed to interact. There is another mode by which 
electron transfer can take place. By absorption of light of suitable wavelength, 
molecules (especially those containing chromophoric groups) can be induced to 
undergo transition fi-om the ground to the excited electronic state. Molecules in the 
excited electronic state are generally very reactive. They are capable of giving up (or 
taking in) an electron if efficient acceptor or donor units are available in the 
neighbourhood. 
The absorption of light provides the impetus for all photochemical reactions. Core 
electrons and electrons in lower energy orbitals are normally not perturbed by the 
absorption of light. However, electrons in high lying molecular orbitals are 
susceptible to photoexcitation in the ultraviolet and visible regions of the 
electromagnetic spectrum. The absorption of light generates an excited state species 
that is generally more reactive than its ground state analog. Most commonly one 
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electron from the highest occupied orbital (HOMO) is promoted into the lowest 
unoccupied molecular orbital (LUMO). 
Photoexcited molecules are able to induce transitory or permanent changes in 
neighboring molecules through an electron transfer pathway. Electronic transitions 
create vacancies in low-lying bonding or non-bonding orbital's, called holes, which 
serve as much better electron acceptors than unoccupied orbitals of higher energy. 
Energy is released upon the transfer of one electron from an orbital of infinite 
separation from the nucleus of the donor into a low-lying, vacant orbital nearer to the 
nucleus of the acceptor. The absorbed light can be converted to chemical energy by 
the transfer of an electron either to or from the excited state species in an energetically 
favorable, exothermic process. 
The energy change associated with the excitation of a bound electron from its orbital 
into an orbital at infinite distance, or the difference in orbital energies between the 
low-lying bonding and higher nonbonding orbitals, is referred to as ionization 
potential (IP) (Fig. 1.4). The reverse process, the amount of energy required to bring 
an electron from an infinite distance into a low-lying vacant orbital, is referred to as 
electron affinity (EA). IP's and EA's are quantities used to describe gas phase 
molecules, which are not directly applicable in describing molecules in solution. 
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Fig. 1.4: IP and EA of both the ground and excited state species. 
The solvation of ions is an important factor in solution phase chemistry, resulting in 
the need for the solution phase analogs of IP and EA, oxidation and reduction 
potentials^". Oxidation potential is the potential at which an electron is removed from 
a molecule, and reduction potential is the potential at which an electron is added to a 
molecule. Variations in oxidation and reduction potentials parallel those in ionization 
potentials and electron affinities. Plots of redox potentials versus ionization potentials 
and electron affinities for structurally related compounds often show linear 
correlations^'. A groimd state example of the redox process is shown in Fig. 1.5, 
where electron transfer occurs between a donor and acceptor molecule. In the ground 
state the free energy change for the electron transfer process is the difference in redox 
potentials of the donor and acceptor. Because of the large HOMO-LUMO gap in the 
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ground state of organic molecules, electron transfer would be a largely endothermic 
process. 
D hv D+ + A"^  
Fig. 1.5: Ground state redox reactions. 
In addition to a donor (D), and an acceptor (A), the PET reactions require an 
electronic excitation source (light). In PET the electronically excited species serves as 
the oxidizing or reducing species, as shown in Fig. 1.6 & 1.7. Here, the free energy 
change associated with electron transfer, which includes the redox potentials of the 
donor and acceptor, is made more negative by an additional term corresponding to the 
excitation energy. Electronic excitation exploits the large HOMO-LUMO gap, 
making electron transfer an energetically more favorable process. 
hv 
D + A 
excitation 
D + A 
„* . electron A* ^ A 
D + A -T r:—• D + A 
transfer 
Fig. 1.6: Excitation of a donor followed by electron transfer. 
Page 24 
D 
hv 
D A D+ . A^ 
Fig. 1.7: Photoinitiated electron transfer. 
Here, the free energy change associated with electron transfer, which includes the 
redox potentials of the donor and acceptor, is made more negative by an additional 
term corresponding to the excitation energy. Electronic excitation exploits the large 
HOMO-LUMO gap, making electron transfer an energetically more favorable 
process. The Rehm-Weller equation^^ (Eq. 3.6) provides a useful expression for 
calculating the free energy change associated with PET reactions. 
A GET = D F I O P D - O P R - AGQO - ^p Rehm- Weller Equation (3.6) 
PET reactions involve the jump of an electron from the occupied orbital of one 
reactant (donor), to the unoccupied orbital of another (acceptor), either of them may 
be photoexcited. In this interaction between a photoexcited electron donor (or 
acceptor) and a ground state electron acceptor (or donor), the reacting partners also 
form charge transfer (CT) complexes. Thus, subsequent to the electron transfer a 
charge transfer state is created, which is a dipolar species, consisting of the radical 
cation of the donor (D+) and the radical anion of the acceptor (A-). On a transfer of 
electron from the donor to an acceptor, contact ion pair (CIP) is formed, which 
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subsequently produces the solvent separated ion pair (SSIP) due to penetration of the 
solvent molecules in CIP. With time SSIP dissociates to free ions (FI). The charge 
transfer state created can undergo many different processes". Thus, the first electron 
transfer is followed by two consecutive steps. Thus a proton coupled electron transfer 
process is accomplished, by which light-energy is converted into an electrochemical 
proton gradient A photoinduced electron transfer from D to A results in the formation 
of a charge separated state which consists of the corresponding radical cation and 
anion, and the process is in direct competition with the radiative and nonradiative 
processes that are present in the excited state of A (or D). Electron transfer can be 
regarded as an extra deactivation path of the locally excited (singlet) state that can 
exist next to internal conversion (ic), inter system crossing (isc) to the triplet manifold 
(both iso-energetic) and emission (f). Thus the occurrence of electron transfer should 
diminish both the emission quantum yield and lifetime. There are, however, other 
mechanisms that can be responsible for fluorescence quenching: e.g. energy transfer, 
proton transfer, hydrogen bonding and the external heavy atom effect. Many other 
reactions exist in which electron transfer is followed by the formation or breaking of 
bonds or the trapping of a charge transfer state, followed by further chemical 
reactions. Another process that can follow charge separation (or forward electron 
transfer) is simply charge recombination (or back electron transfer, BET) leading to 
the initial state. This is in fact a very common process, which is often the fate of a 
charge transfer state. This charge recombination can occur by a dark (non-radiative) 
process, but there exist many systems in which the charge transfer state undergoes a 
radiative charge recombination. The wavelength of the emission of this process (often 
called charge transfer fluorescence or, more accurately, charge recombination 
fluorescence) is very dependent on the environment of the dipolar charge transfer 
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state. Thus, BET is an energy wastage process in a PET reaction without giving any 
net resuh. If an electron donor or an acceptor undergoes cleavage of any of their 
bonds immediately following the ET, dissociative electron transfer (DET) reactions 
i.e. ET reactions followed by bond breaking are observed over the energy wasting 
BET process. Since BET has an appreciable thermodynamic driving force and are 
quite fast, thus the kinetic suppression of BET often becomes the limiting factor to 
observe the desired or undesired chemistry following the PET process '^*. Different 
steps in a PET reactions and a representation of the several possibilities that a charge 
separated state can undergo are shown in the Fig. 1.8 and Fig. 1.9. 
(DA) 
D+ + A-
Fl 
D= Electron donor 
A= Electron Acceptor 
DA=CT complex between D&A 
CIP =contact ion pair 
SSIP==solvent separated ion pair 
FI = free ions 
BET= back electron transfer 
Fig. 1.8: Different steps in a PET reaction. 
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D*+ A-
electron 
transfer 
D + A 
non-radiative 
hv recombinationj 
excitation 
D + A 
radiative 
recombination 
further 
electron 
transfer steps 
bond formation 
or breaking 
D2' + D + A • 
Fig. 1.9: Representation of the several possibilities that a charge separated state can 
undergo. 
A collection of examples from literature are presented here to highlight the 
researches on photosensitizing-phototoxic drugs for their mechanism of 
photodegradation audits correlation to phototoxicity. 
Dihydropyridine Drugs: 
Amlodipine^^ (1) belongs to a class of drugs called calcium channel blockers 
demonstrate phototoxicity. When the drug in water was exposed to sunlight the only 
photoproduct (2) was found. Formation of this product was explained on the basis of a 
radical cation intermediate formation through photoinduced electron transfer 
mechanism (Scheme l.l). The intervention of radical in it suggests that drug has 
phototoxic effect. 
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hv 
-H* -2e 
HaCOzC^C^COzCHaCHj 
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H3CO2C 
cnr ">i s'olv. solv.H* l! ' * 
Scheme 1.1 
Bamidipine^^ is a new generation of 1, 4-dihydropyriciine calcium-ciiannel blockers 
widely used against hypertension and angina. The 1, 4-dihydropyridine 
antihypertensive are well-known photosensitive drugs. The photodegradation ol' 
bamidipine was performed by exposing the drug to natural and stressing light 
irradiation. The drug, under direct or indirect sunlight, underwent oxidation 
generating the pyridine derivative as the main photodegradation mechanistic product, 
according to most of the drug congeners. 
3-nitrophenyl derivatives (PyH2-PhN02) are photolabile drugs. This is due to 
intramolecular electron transfer between the close-lying donor and acceptor moieties 
to give the charge-separated species (PyH2**-PhN0''). When a alkylamino group is 
present, oxidative degradation of that moiety occurs, again via an electron-transfer 
intramolecular process. Nicardipine drug is more efficient drug, donor-acceptor dyads 
of this type, easily available through the Hantzsch synthesis, may be useful for 
building new photoinduced electron-transfer systems^^. The intervention of radical in 
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it suggests that drug has phototoxic effect. Irradiation of 4-oxo-2, 2, 6, 6-
tetramethylpiperidinyl-1-oxy radical (TEMPO), a nitroxide, with 4-substituted 
Hantzsch 1, 4-dihydropyridines (3) in CH3CN, gives aromatic products (4) through a 
photoinduced electron transfer mechanism^* (Scheme 1.2). The generation of radical 
in the photodegradation pathway is responsible for the observed phototoxicity of this 
drug. 
H xR 
E t O O C ^ > < / C O O E t 
Me'^^N Me 
H 
(3) 
TEMPO 
0^ hv / 
TEMPO 
H R 
E t O O C , > < _ , C O O E t 
M e ^ ^ N Me 
H 
E t O O C J x 
M e - ^ N " 
(4) 
X O O 
Me 
EtOOC, 
Me' 
Et 
Hv R 
<_ /COOEt 
•X 
N Me 
s ^ 
s ° 
X 
Scheme 1.2 
Nimodipine and felodipine (5) are calcium channel blockers of the second-generation 
of 1, 4-dihydropyridines (1,4-DHPs), which are widely used as antihypertensive drugs 
its reaction with singlet oxygen result in the formation of dihydropyridine localized 
triplet or to pyridine derivative as main photodegradation product (6) produced by 
intramolecular electron transfer via a zwitterionic biradical intermediate^^(Scheme 
1.3). Reaction of singlet oxygen with two other 1-4 dihydropyredines derivative 
nifedipine and nitrendipine was studied. Which follows similar mode of action^'' as 
described above (Scheme 1.4). The phototoxicity of these drugs involved type -II 
photodynamic action. 
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HaC. 
(5) 
^O, 
-H2O2 
H,C, 
Scheme 1.3 
(6) 
^02 
-H,0 2^2 
Nifedipine R^  sRj = CHj; 0-NO2 
Nifedipine R^ ^ cHj.Rj = C2H5 ; m-N02 
Scheme 1.4 
Nonsteroidal anti-inflammatory Druss: 
Carprofen^' (7) is a photosensitizing nonsteroidal anti-inflammatory drug. It 
undergoes photodehalogenation from its triplet excited state. The resulting aryl radical 
is able to abstract hydrogen atoms model lipids, mediating their peroxidation by a 
type-I mechanism. This aryl radical intermediate appears to be responsible for the 
observed photobiological effect of carprofen. A photodecompation of carprofen (7) 
and its major photoproduct (9) are shown in Scheme 1.5 and 1.6. 
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Scheme 1.5 
Minor photodecarboxylated product was obtained from the excited singlet state, 
which leads to the formation of an acetyl derivative (8), dehalogenated (9), 
photodecarboxylation to the ethyl (10) and acetyl (11) derivatives. 
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Scheme 1.6 
Ketoprofen^^ (12) is a nonsteroidal anti-inflammatory drug (NSAID) which was used 
in the treatment of analgesic and antipyretic effects. It acts by inhibiting the body's 
production of prostaglandin and it exhibited the phototoxic effect. Two 
photodegraded products (13) and (14) were isolated through electron transfer 
photodegradation mechanism (scheme 1.7) 
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Scheme 1.7 
Indoprofen" (15) is a nonsteroidal anti-inflammatory drug (NSAID) which was used 
in the treatment of both osteoarthritis and rheumatoid arthritis and exhibited the 
phototoxic effect. In aqueous buffer solution Indoprofen undergo 
photodecarboxylation results the formation of four oxidative photoproducts whose 
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proportions increase with increasing oxygen concentration. The mechanism outlined 
in scheme 1.8. The phototoxicity of this drug have been proposed to occur through 
type -I mechanism. 
hv,- CO2 
Scheme 1.8 
-64 Fenofibrate"^ (20) is a NSAID drug of the fibrate class. It is mainly used to reduce 
cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates, it 
reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) 
levels, as well as increasing high-density lipoprotein (HDL) levels and reducing 
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triglycerides level. It is used alone with statins in the treatment of 
hypercholesterolemia and hypertriglyceridemia. Fenofibrate (20) (FF) under aerobic 
and anaerobic conditions at room temperature is a photolabile drug. The major 
products of the photolysis of fenofibrate in methanol under argon atmosphere are the 
solvent adduct (21), the hydrodimer (22) and minor amounts of the phenol (26) 
(Scheme 1.9). 
CI 
FF (20 
O 
II 
C-R 
"CH2OH 
HO-C-CH2OH 
CI 
(21) 
•CH2OH 
C - O 
OH 
O, Q_^  
"C-OCH3 ' C - O H 
I b-C-CH3 
CI 
(23) 
CI 
(24) 
CI 
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Scheme 1.9 
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Red blood cell lysis photosensitized by phototoxic drug naproxen^^ (27) was 
investigated. The irradiation of deaerated solutions of naproxen underwent a 
decarboxylation process via intermediate radicals, while under aerobic conditions 
photo-oxidation leading to the photoproducJt 6-methoxy- 2-acetonaphthone (29) 
occurred. A molecular mechanism involving free radicals and singlet oxygen as 
important intermediates and consistent with the overall results is proposed (Scheme 
1.10). 
CH 
Ar 
(27) 
hv 
H3C / .COO 
CH 
Ar 
O2 
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H^  
H3C. / O O H 
CH 
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(28) 
Ar = H3COC 
Scheme 1.10 
H,C. 
CH + CO2" 
Ar 
H3C. 
"CO + H2O 
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(29) 
Red blood cell lysis photosensitized by photosensitizing drug Suprofen^^ (30) and the 
photolysis of the drug were investigated. Photolysis of the drug at 310-390 nm in 
deaerated buffered solutions (pH 7.4) leads to a decarboxylation process with the 
formation of p-ethyl phenyl 2-thienyl ketone (31), whereas in aerated solutions 
formation of photoproduct I and of the photoproducts p- acetyl phenyl 2-thienyl 
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ketone (32) and p-(l-hydroxyethyl)phenyl-2- thienyl ketone (33) occurs. The overall 
results of SPF photodegradation and a hemolysis demonstrated that cell damage is 
provoked. Principally by the direct attack of drug radicals and secondarily by singlet 
oxygen and hydroxyl radicals (Scheme 1.11). 
H3C. ^ C O O 
CH 
Ar 
(30) 
hv 
H3C. ^ C H a 
CH 
H3C. ,COO 
CH 
I 
Ar 
Hemolysis 
- * Hemolysis 
•- Hemolysis 
Ar = 
CO.^  s X> 
IVI= Cell membrane 
Scheme 1.11 
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The lysis of red blood cells photosensitized by diflunisal^^ (34) was investigated. 
Direct irradiation of DFN in buffer solution at pH 7.4 leads to the formation, under 
anaerobic conditions, of compound 2'-(2"',4"'difluoro-3"-carboxy-] 1", 1 '"-biphenyl] 
4"-oxy)-4'-fluoro-4-hydroxy-[ 1,1 '-biphenyl] -3-carboxylic acid (35), whereas under 
aerobic conditions formation of 35 is accompanied by unidentified photo-oxidation 
products; only compound 35 displays strong lytic activity. The overall results for 34 
photosensitized hemolysis suggest a mechanism involving a concerted action of free 
radicals, superoxide anion, singlet oxygen and sensitizer photoproducts (Scheme 
1.12). 
+ F 
Scheme 1.12 
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Tiaprofenic acid^* (36) is a NSAID of the arylpropionic acid (profen) class, used to 
treat pain, especially arthritic pain. It is sparingly metabolised in the liver to two 
inactive metabolites. One major photoproduct (38) was isolated through electron 
transfer mechanism (scheme 1.13) 
*" Photodegradation 
Adduct formation 
(38) 
Scheme 1.13 
The novel anti-inflammatory drug benzydamine^^ when irradiated in aerated 
solutions, competing pathways of photosensitization are possible, namely, singlet 
oxygen mediated oxidation, and electron-transfer mechanisms. The ability of 
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benzydamine to participate as sensitizer in several types of photochemical reaction is 
relevant to the observed clinical photosensitivity of the drug. 
The phototoxic drug thio-colchicoside (2-dimethoxy-2-glucosidoxythiocolchicine). 
is photolabile under irradiation with UV-A light in aerobic and anaerobic conditions. 
Irradiation of a methanol solution of thio-colchicoside produces two photoproducts 
without a glucoside group. One of these lost the methyl thio-group, while the other is 
oxidized (only under aerobic conditions) to sulfoxide. Thio-colchicoside was screened 
in vitro in different concentrations for UV-Vis-induced phototoxic effects in a 
photohemolysis test, in the presence and absence of different radical scavengers. 
singlet oxygen and superoxide radical quenchers. Studies on peripheral blood 
mononuclear cells (lymphocytes) demonstrated phototoxic effects on them. Protection 
by GSH, DABCO, sodium azide and SOD are indicative of both Type I and II 
photosensitization pathways mediated by free radicals and singlet molecular oxygen. 
Antineoplastic Druss: 
Tirapazamine^' (39) is a potential antitumor phototoxic drug. It has been found to be 
capable of acting selectively in hypoxic environments found in rapidly growing 
tumors. One of the proposed mechanisms of action of this compound is shown in 
Scheme 1.14; enzymatic electron transfer and subsequent proton transfer to generate 
the radical, which undergoes p-fission to generate 3-aminobenzo-l, 2, 4-triazine- A^ -
oxide (40) and hydroxyl radical, which is well established as a promoter of nucleic 
acid cleavage (phototoxicity) (Scheme 1.14). 
Page 41 
Scheme 1.14 
The phototoxic anti-cancer drug flutamide^^ (43) is photolabile under UV-B light in 
either aerobic or anaerobic conditions. Irradiation of a methanol solution of this drug 
produces several photoproducts, one by photoreduction of the nitro group, one by 
rupture of the aromatic-NO bond of the parent compound, two as a result of the 
rupture of the CO-NH bond and one derived from the photoreduction product by 
scission of the aromatic-NH2 bond. The phototoxicity of Flutamide was shown to 
occure through radical mediated (type-1) process (Scheme 1.15). 
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Decarbazine is clinically effective in the treatment of several malignant disorders. 
including metastatic malignant melanoma, Hodgkin's disease and soft tissue 
sarcomas, in combination with other anticancer drugs. This drug induces 
photosensitizing effect in patient treated with it. On UVA-irradiation photoactivated 
decarbazine generates the carbene and aryl radicals, which may induce both DNA 
adduct and 8-oxodG formation, resulting in photogenotoxicity^^ 
A spectroscopic study of irradiated photosensitizing drug camptothecin in the 
presence and absence of copper has been performed to explore and identify the radical 
species generated in these processes. The reported result indicated that camptothecin 
is a promising photosensitizer and that radicals and singlet oxygen generated upon 
illumination play a central role in DNA cleavage and in the induction of apoptosis in 
cancer cells. 
Antipsychotics Phenothaizine Druss: 
Amitriptyline^^ (49), Nortriptyline is a tricyclic antidepressant drug. This drug induces 
photosensitizing reactions in humans, as an adverse effect .Upon UV-A irradiation it 
photochemically transformation into photoproduct (50) and (51). The phototoxicity of 
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amitriptyline can be attributed to radical formation via Type I mechanism (Scheme 
1.16). 
a 
clevage 
(50) H 
Scheme 1.16 
2-chlorophenothiazine^^ (52) is a tricycle antidepressant drug. The molecular structiu^e 
of halogenated phenothiazine i.e. 2- chloropromazine and their phototoxic side effects 
were studied in several alcoholic solvent media through an electron transfer 
mechanism, the alkylamino chain can transfer an electron to the phenothaizine moisty 
resulting (53) and (54) which were obtained as a photoproducts (Scheme 1.17). 
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Scheme 1.17 
Phenothaizine derivatives have attracted much interest for a long time due to their 
diverse chemical and biological properties, as well as medical applications. The 
radical cation of phenothiazines is believed to be involved in the biotransformation of 
phenothiazine drugs. Photoirradiation of a N-alkylphenothiazine (55a, 55b and 55c) 
• 77 
drugs m CCI4 solution produced a dark-brown precipitate of two photoproducts (56) 
and (57) (scheme 1.18). 
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Cyamemazine^ '^^ ^ (58) (CMZ) is a phototoxic neuroleptic phenothiazine drug having 
a strong skin phototoxic response in humans. UVA absorbing properties of phototoxic 
drug cyamemazine (CMZ) have been investigated in neutral buffered aqueous 
solutions, resulting two major photodegraded products formed by the oxidation of the 
sulfur atom (59) and other oxidative photoproduct formed by the further oxidation of 
the side chain nitrogen (60). These photoproducts are a good Type-I and Type-II 
photodynamic photosensitizer producing singlet oxygen (scheme 1.19). 
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(60) 
Diuretic and Anti-diabetes Drugs: 
The phototoxic diuretic drug furosemide*° (61) is photolabile under aerobic and 
anaerobic conditions. Irradiation of a methanol solution of 61 under oxygen produces 
photoproducts 62, 63, 64 and singlet oxygen, while under argon the photoproducts 62 
and 64 were isolated. The result indicated that phototoxicity mechanism for this drug 
most probably involves reactions of singlet oxygen and superoxide oxygen with 
cellular components than reactions of a free radical intermediate or stable 
photoproducts (Scheme 1.20). 
The phototoxic diuretic drug acetazolamide^' (65) is photolabile under irradiation 
with UV-B (at 300 run) light in aerobic. Also photodegradation of 246 with UV-A 
light (at 337 nm, N2 laser) and photosensitizing degradation with rose bengal was 
observed. Two photoproducts were isolated and identified. In both the cases the same 
photoproducts were obtained. Photo-sensitization reactions were involving singlet 
oxygen lead to decomposition of acetazolamide. Acetazolamide has been shown to 
Page 47 
photosensitize the reduction of nitro blue tetrazolium in PBS, which is more efficient 
in deoxygenated conditions and quenched in presence of SOD. 
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Scheme 1.20 
These resuks indicate that direct electron transfer occurs from the excited state of 65 
to the substrate, and also that superoxide could be involved as an intermediate when 
oxygen is present (Scheme 1.21). 
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Scheme 1.21 
Xipamide^^ (68) is a potent non-thiazide diuretic drug. It has a greater natriuretic 
effect than the thiazides and a less abrupt onset and longer duration of action than 
fiirosemide. It is an effective antihypertensive drug, appears to be a more effective 
diuretic than the thiazides and may cause a lower potassium loss relative to sodium 
excretion than these drugs. Photolysis of xipamide under UV-A light resulted in the 
formation of two major photodegradation products (69) and (70) through an electron 
transfer mechanism shown in scheme 1.22 
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Scheme 1.22 
Clopamide" (71) IS an oral diuretic drug that shares the same aromatic sulfonamide 
base as the thiazide diuretics. It has similar properties to thiazide class diuretics which 
act on the inhibiting re-absorption of sodium in the proximal renal tubule and 
stimulating chloride excretion. Clopamide are being more widely used for the 
treatment of hypertension & excessive fluid retention as in cardiac failure, cirrhosis, 
chronic renal failure, nephrotic syndrome and cushing's disease. When clopamie was 
irradiated in presence of UV light, two photoproducts (72) and (73) were isolated 
through an electron transfer mechanism shown in scheme 1.23 
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Scheme 1.23 
The antidiabetes drug gliclazide*'* (74) is photo labile under aerobic condition and 
UV-B light. Irradiation of a phosphate buffered solution of gliclazide under oxygen 
atmosphere produces two photo products as 75 and 76. The photochemistry of (74) 
involves cleavage of the S-N and C (0)-N bonds (Scheme 1.24).the reported result 
indicated that gliclazide have shown radical mediated (type-I) phototoxicity. 
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Antibacterial and antiviral Drues: 
The photochemical reactions in vitro of antibacterial drugs sulfamethoxazole alone 
and in combination with trimethoprim have been studied to obtain information on the 
photosensitization mechanism. Sulfamethoxazole in aqueous solution, on exposure to 
UVB radiation, generates free radicals and singlet oxygen, with the neutral molecule 
being at least twice as active as the sulfamethoxazole anion. Photoexcited 
sulfamethoxazole can participate in electron transfer to Cytochrome-C and nitro blue 
tetrazolium, and sensitizes the peroxidation of linoleic acid and the hemolysis of 
human erythmcytes, predominantly by a free radical mechanism. Trimethoprim is 
relatively inactive in the same photochemical systems^^ 
Amodiaqume (77), an antimalarials drug possesses undesirable photosensitizing 
properties that produce phototoxic side effects in both the skin and the eye. UV 
irradiation of Amodiaquine leads the formation of photoproduct produced through 
concerted cycloaddition of singlet oxygen to the aminophenolic ring of this drug 
(Scheme 1.25). The study indicated that singlet oxygen formation account for the 
observed phototoxic effect of this drug. 
Page 52 
CI 
^N^% 
OH 
CH2 N(CH2CH3)2 
^ 0 2 ( % ) - ^ 
H ^CH2 N(CH2CH3)2 
(77) 
o 
o. 
c 
o 
sr 
Scheme 1.25 
Fluoroquinolones Druss: 
Quinolone antibiotics bearing fluorine substituent are commonly called 
fluoroquinolones. The photobehaviour of fluoroquinolone antibiotics has recently 
been the object of increasing interest due to the finding of their phototoxic and 
photocarcinogenic properties. In last few years FQs have drawn much attention due to 
their antitumoral activity. In vitro and in vivo studies have corroborated the anticancer 
effects of quinolone antibiotics supporting the observation that FQs reduce all-cause 
mortality among cancer patients. Fleroxacin and lomefloxacin (LFX) (78) have shown 
not only a photoinduced genotoxicity but also photoxicity and photoallergy. An 
intramolecular electron transfer occurs in between the lone pair of nitrogen and the 
quinolinic ring ' (path I, Scheme 1.26). 
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Vasoreeulator Druss: 
The potential phototoxic activity of naphazoiine*^ (NP), 2-(l-naphthylmethyl) 
imidazolone (83), belongs to the vasoregulator class of drugs was investigated by 
studying its photoreactivity towards DNA. Photocleavage studies combined with laser 
flash photolysis experiments provide clear evidence that the transient species 
produced under NP photolysis react with DNA, thereby promoting its breakage under 
both aerobic and anaerobic conditions (Scheme 1.27). 
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Beta-blocker Druss: 
The photochemistry of phototoxic drug propranolol (PR), l-isopropyIamino-2-(l-
naphthyloxy) propan-2-ol (84) belongs to a wide group of drugs classified as beta-
blockers, has been studied. PR photodecomposition takes place in an aerated aqueous 
medium and leads to 6-hydroxy-l,4-naphthoquinone (85) as the sole stable 
photoproduct, Formation of this photoproduct demonstrated that photodegradation 
occurs via a type II mechanism involving irreversible trapping of self-photogenerated 
singlet molecular oxygen^° (Scheme 1.28). 
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Liyid-lowerine and Anaesthetic Drugs: 
Atorvastatin calcium (86) is one of the most frequently prescribed drugs worldwide. 
Among the adverse effects observed for this lipid-lowering agent, clinical cases of 
cutaneous adverse reactions have been reported and associated with photosensitivity 
disorders. On the basis of the obtained photophysical and photochemical results, the 
phototoxicity of atorvastatin can be attributed to singlet oxygen formation with the 
phenanthrene-like photoproduct as a photosensitizer (Scheme 1.29). 
The phototoxic HMG-CoA Reductase Inhibitor drug fluvastatin (92) underwent 
rapid photodegradation upon Ultraviolet-A (UVA) irradiation in buffered aqueous 
solution to give benzocarbazole-like photoproduct (93) .the phototoxicity of 
fluvastatin may be mediated by the formation of benzocarbazole-like photoproduct 
that acts as strong photosensitizer (Scheme 1.30). 
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The reaction between the anaesthetic agent 2, 6-diisopropylphenol (propofol, PPF. 
94) and singlet oxygen (^ Oz) has been investigated in aqueous solution. The reaction 
of propofol with singlet oxygen produced by light irradiation of Rose Bengal leads 
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essentially to two reaction products, 2,6-diisopropyl-p-benzoquinone (95) and 
3,5,3',5'-tetraisopropyl-(4,4')-diphenoquinone (96) ( Scheme 1.31) 
+ 3 Q 2 
PPF 
2,6-diidopropylphenoxyl radical.PPF-
Diphenol 
(95) 
PPF 
^02 
Scheme 1.31 
Antidepressant and Antiplatelet Drugs: 
Lamotrigine '^* an anticonvulsant and antidepressant drug produces a (photo) toxic 
response in some patients. Lamotrigine absorbs UV light, generating singlet oxygen 
('O2) small production of superoxide radical anion was also detected in acetonitrile 
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Thus, Lamotrigine is a moderate photosensitizer producing phototoxicity and 
oxidizing linoleic acid mainly by the contribution of singlet oxygen. 
The photochemical reactions of dipyridamole (97), a healing agent were studied. Its 
photolysis product under UV-A and aerobic conditions was isolated as 98. The 
photodegradation of dipyridamole occurs probably via a type II mechanism involving 
irreversible trapping of self-photogenerated reactive oxygen species (ROS). The 
formation of singlet oxygen and superoxide during the dipyridamole 
photodegradation makes one suspicious of a possibility that dipyridamole could also 
be involved in oxidative stress in biological systems^^ (Scheme 1.32). 
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Scheme 1.32 
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Triflusal is a platelet antiaggregant drug'^ with photoallergic side effects. However, it 
is considered a prodrug since it is metabolized to 2-hydroxy-4-trifluoromethylbenzoic 
acid (99) the pharmacologically active form. It was found to be photolabile under 
various conditions. Its major photodegradation pathway appears to be the nucleophilic 
attack at the trifluoromethyl moiety. The photobinding of 99 to proteins such as 
bovine serum albumin has been demonstrated using ultraviolet-visible (UV-Vis) and 
fluorescence spectroscopy. Nucleophilic groups present in the protein appear to be 
responsible for the formation of covalent drug photoadducts, which is the first step 
involved in the photoallergy shown by triflusal (Scheme 1.33) 
hv 
ROH (R=H or CH3) 
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R=CH3 ;HTIVIE 
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Scheme 1.33 
The isolation and identification of the photodegradation products of photosensitizing 
antidepressant drug clomipramine^^ in phosphate buffered saline (PBS pH 7.4 and 6.0) 
solution and methanol under aerobic conditions were studied. Six compovmds were 
identified and four of them were isolated and characterized by spectroscopic methods. 
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A radical mechanism with the participation of the solvent is proposed for the 
photodegradation of clomipramine which undergoes homolytic cleavage of the 
carbon-chlorine bond and also photooxidation of the amine group. A mechanism 
involving singlet oxygen, radicals and photoproducts is suggested for the reported 
phototoxicity of this drug. 
trazodone (101), a largely used antidepressant at 310 nm in water has been 
investigated. Presumably produced three photoproducts, firstly formed product 102. 
produced by the photoionization of the benzene ring is the primary photochemical 
process, followed by the nucleophilic attack of the solvent to the radical cation and 
loss of HCl. Product 103 and 104 are formed from product 102. Product 103 is 
produced by a peculiar dimerization of the dihydropyridine moiety^^ (scheme 1.34). 
(lO-H *iioi)* 
-e" 
-(CH2)3-N 
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R= —(CH2)3 
H2O HCl 
CI O (102) OH 
O R 
''w^A^ J. N-R 
OH O 
(103) 
hv 
(213)* ^ 13. 
(104) 
Scheme 1.34 
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Antifolate Drugs: 
Talotrexin^ (105) is antifolate drug, used as an antimetabolite analogue of 
aminopterin with potential antineoplastic activity. Talotrexin binds to and inhibits the 
function of dihydrofolate reductase, resulting in the inhibition of folate metabolism, 
DNA synthesis, and cell division. It has combines characteristics of both the classical 
and non classical antifolates. Talotrexin enhanced the antitumor activity in a broad 
spectrum of cancer models by targeting the enzyme DHFR to prevent DNA synthesis 
in tumor cells and inhibit tumor growth. Photolysis of talotrexine (105) resulted in the 
formation of three photodegradation products (106), (107) and (108) by a 
photoinduced electron transfer (both inter and intra molecular) mechanism shovwi in 
scheme 1.35 
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Anticancer Drugs: 
Vandetanib" '^^  (109) is an anti-cancer drug that is used for the treatment of 
unresectable or metastatic medullary thyroid cancer (MTC). Phototoxicity of drugs 
can derive from the classical photochemical reactions with the formation of radical 
oxygen species or singlet oxygen. Two main photoproducts were isolation and 
structural characterization in the presence of UV radiation, the typical C-Br bond 
homolysis can occur, leading to an aryl radical (110). The resulting radical can 
undergo electron transfer to form an aryl cation, which can be readily attacked by 
nucleophiles such as water (HI) . The simple photodehalogenation led to (112) 
(Scheme 1.36). 
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The photochemistry of pharmaceuticals is an area of growing concern as the number 
of drugs found to be photosensitive-phototoxic is increasing. Since all the adverse 
photobiological effects produced by photosensitizing-phototoxic drugs are the 
consequences of photochemical reactions, it is important to stimulate more chemists 
to work on the molecular basis of photobiological problems. 
The dated interest of photochemists in the properties of the electronically excited 
states of compounds of pharmaceutical use has been rapidly increasing during the last 
decade. This is not only connected to the increasing number of cases of drug-
photoinduced disorders, but it has also attracted considerable attention from a more 
fundamental photochemical standpoint. Thus, it is worthy to stress that studies 
performed on drugs bearing either simple or complex chromophoric structures have 
provided remarkable contributions to the broad area of the molecular mechanisms of 
photo-initiated reactions. 
The molecular mechanism of photosensitization induced by drugs can proceed 
through several pathways and may involve the presence or absence of oxygen, leading 
to a very complicated picture. However, it is important to note that chemically there 
are two main types of photosensitization caused by excited sensitizer: Type I (direct 
radical mediated-reactions) and Type II (singlet oxygen-mediated reactions). Many 
important photosensitization reactions are Type I processes, and the study of the 
biological effects of radical produced via electron transfer process in 
photosensitization reactions is an important area of research in modem photobiology. 
A number of photosensitizing drugs have been shown to undergo photoionization and 
participate in electron-transfer processes and subsequent photoinduced fragmentation 
reactions. The one-electron transfer process within the excited donor-acceptor pair 
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produces initial radicals which undergo further secondary reactions, leading to the 
formation of stable products. Associated with its own chromophoric structural 
features, it is the individuality of the drug to follow the course of photodegradation 
and photosensitization. It is, therefore, important to clarify and to explain the reaction 
pathways and to identify the short-lived intermediates, as well as the stable products, 
resulting from photoreactions of each and every drug. 
In order to contribute to the photochemistry of photosensitizing drugs for the 
elucidation of their molecular mechanisms of photodegradation and 
photosensitization, a systematic investigation on the photoinduced electron transfer 
degradation of some photosensitizing drugs has been carried out under different 
reaction conditions, and presented in Chapter 2. 
Page 65 
References 
1. http:// www.Pol-us.net/Asp Home/asp br02.html. 
2. Sunlight, Ultraviolet Radiation, and the Skin. NIH Consens Statement 1989 
May, 7 ,1 . 
3. R. A. Larson, Phytochemistry, 1988,27, 969. 
4. J. P. Knox, A. D. Dodge, Phytochemistry, 1985, 24, 889. 
5. http://www. Chem.ucla.edu/dept/organic/ CSF_Brochure.html. 
6. D Saha, A. Tamrakar, Asian J. Res. Pharm. Sci. 2011,1, 36. 
7. G.M.J. Bejersbergen van Henegouwen, J.Photochem. photobiol. B: Biol. 
1991,10,183. 
8. A. R. Wielgus, J. E. Roberts, Photochem. Photobiol, 2012, 88, 1320. 
9. F. Urbach, J. D. Regan, J. A. Parrish, The Sci. of Photomedicin, Eds., Plenum 
press. New York 1982, p 261. 
10. L. H. Kligman, A. M. kligman, Photodermatol, 1986, 3, 215. 
11. I. Abramov, R. J. Wurtman, M. J. Baum, J. T. Potts Ed., The New York 
academy of science. New York, 1985, vol. 453, p 365. 
12. M. B. McElory, R. J. Salawitch, Science, 1989, 243, 763. 
13. S. Onoue, Y. Tsuda, Pharm Res, 2006, 23, 156. 
14. M. A. Miranda, Pure Appl. Chem, 2001, 73, 481. 
15. F. Bosca, M. A. Miranda, J.Photochem. photobiol.B: Biol. 1998, 43, 1. 
16. S. Sortino, G. Cosa, J. C. Scaiano, New J. Chem., 2000, 24, 159 
17. S. Onoue Y. Seto G. Gandy S. Yamada, Curr Drug Saf, 2009, 4, 123. 
18. A Gilbert, J. Baggott, Essentials of Molecular Photochemistry, pp. 145-228. 
Oxford: Blackwell. (1991). 
Pagei 
19. H. H. Tonnesen, in: Photostability of Drugs and Drug Formulations, H. H. 
Tonnesen Ed., Taylor and Francis, London, 1996. 
20. D.E Moore, Drug Saf. 2002, 25, 345 
21. M. R. Bhalekar, D. Harinarayana, A. R. Madgulkar, S. J. Pandya, D. K. Jain, 
Asian! Chem, 2008, 20, 5095. 
22. K. A. K. Musa, L. A. Eriksson, J. Phys. Chem. B, 2009,113, 11306. 
23. G. Condorelli, L. L. Costanzo, G. De Guidi, S. Giuffrida, P. Miano, S. Sortino, 
A. Velardita, EPA News!., 1996, 58, 60. 
24. A. Gupta, W. Ahmad, M. R. Zaheer, J. Iqbal, D. Pharmacia Sinica, 2012, 3 
(3), 312-316. 
25. M. Goncalo, Phototoxic and Photoallergic Reactions, Springer V. B. 
Heidelberg 2010. 
26. J. V. Greenhill, M. A. McLelland, Prog. Med. Chem., 1990, 27, 51. 
27. D. E. Moore, J. Pharm. Biomed. Anal, 1987, 5, 441. 
28. F. Vargas, C. Rivas, M. A. Miranda, F. Bosca, Pharmazie, 1991, 46,767. 
29. F. Bosca, M. A. Miranda, L. Vano, F. Vargas, J. Photochem. Photobiol, A: 
Chem, 1990,54,131. 
30. D.E Moore, Mutat. Res. 1998, 422, 165. 
31. M.A Miranda, J.V. Castell Ed. academic press. London. 1997, pp. 289-315. 
32. B. V. Henegouwen, G.M.J. Pharmaceutisch Weeklab, Sci. Ed. 1981, 3, 85-95. 
33. B.V. Henegouwen, G.M.J. Advances in Drug Research. 1997, 29, 79-170. 
34. M.A. Miranda, Farmaindustria. M. Spain, J.V. Castell, M.J.G. Lechon, 1992, 
pp. 239-270. 
35. H. Spielmann, W.W. Lovell, E. Holzle, B.E. Johnson, T. Maurer, M.A. 
Miranda, W.J.W. Pape, O. Sapora, D. Sladowski, ATLA, 1994, 22, 314-348. 
Page ii 
36. J.D. Spikes, K.C.Smith, New York, Plenum Press, 1989, pp 79-110. 
37. J.D. Spikes, J.Photochem. Photobiol. B Biol., 1998, 42, 1-11. 
38. R. C. Guedes, L. A. Eriksson, Photochem. Photobiol. Sci., 2007, 6. !089~ 
1096. 
39. S. B. Kumar, J. Pharm. Sci. & Res., 2013, 5(12), 275 - 276. 
40. M. A. Miranda, in vitro methods in pharmaceutical research, phototoxicity of 
drugs, 1997. 
41. Ph.D Thesis, tel-00408757, version 1 - 3 Aug 2009. 
42. B. Quintero, M. A. Miranda, Ars Pharmaceutica, 2000, 41(1), 27-46. 
43. M. A. Miranda, H. Gar, American Chemical Society, Chem. Rev. 1994, 94. 
1063-1089. 
44. D. Lednicer, Sec. Ed., Strategies of organic drug synthesis and design, John 
Wiley & Sons, 2009. 
45. J. Mattay, A. Griesbeck,; eds. VCH ,Verlagsgesellschaft mbH, Weinheim. 
1994. 
46. H. Kisch, W. Lindner; Chemie in Unserer Zeit, 2001, 35, 250-257. 
47. C. Aubert, M.H. Vos, P. Mathias, A.P. Eker, K. Brettel, K., Nature 2000, 407. 
926-926. 
48. A. G. Schultz, Chem. Commun. 1999,14, 1263-1271. 
49. M. Ishihara, S. Fujisawa, in vivo, review, 2007, 21, 163-174. 
50. D. D. M. Wayner,D. J. McPhee, D. Griller, J. Am. Chem. Soc. 1988, 110, 
132-137. 
51. L. Eberson, Adv. Phys. Org. Chem. 1982,18, 79-185. 
52. D. Rehm, A. Weller, Is. J. Chem. 1970, 8, 259-271. 
Page iii 
53. N. Sukhendu, Photoinduced Dissociative Electron Transfer (PDET), Bare 
News. 
54. R. M. Williams, Introduction to Electron Transfer, May 1, 2007. 
55. M. D. Greca, M. R. lesce, L. Previtera, M. Rubino, V. Barone, O. Crescenzi, 
J. Photochem. Photobiol. A-Chem, 2008,199, 353. 
56. G. loele, F. Oliverio, I. Andreu, M. D. Luca, M. A. Miranda, G. Ragno; J. 
Photochem. Photobio. A: Chem. 215 (2010) 205-213. 
57. E. Fasani, M. Fagnoni, D. Dondi, and A. Albini; J. Org. Chem. 2006, 71, 
2037-2045. 
58. M. Lu, J. G. Fang, Z. Li Liu, L. M. Wu, Chin. Chem. Lett, 2002,13, 923. 
59. N. Pizarro,G. Gunther ,L. J.Nunez-Vergara, J. Photochem. Photobiol. A-Chem 
2005,175, 129. 
60. N. Pizarro, G. Gunther, L. J.Nunez-Vergara, J. Photochem. Photobiol. A-
C/zew 2007,189,23. 
61. F.Bosca, S. Encinas, P. F. Heelis, M. A. Miranda, Chem. Res. Toxicol. 1997, 
10, 820. 
62. F. Bosch. M. A. Miranda, G. Carganico, D. Mauleon, J. Photochem. 
Photobiol. 60, 1994, 96-\0\. 
63. N. Pizarro, G. Gunther, L. J.Nunez-Vergara, J. Photochem. Photobiol. A-
Chem 2007,189,23. 
64. F. Vargas, N. Canudas, M.A. Miranda, F. Bosca, J. Photochem. Photobiol.5%, 
1993,471-476. 
65. L. L. Costanzo, G. De Guidi, G. Condorelli, J. Photochem Pholobiol B-Biol, 
1989,3 223. 
Page iv 
66. G. De Guidi, R. Chillemi, L.L. Costanzo, S. Giuffrida, S. Sortino and G. 
Condorelli, J. Pholochem Pholobiol B-Biol, 1994 ,23 125. 
67. G. De Guidi, R. Chillem, S. Gitirida, G. Condorelli, M. Cambria Fama../. 
Pholochem Pholobiol B-Biol, 1991 ,10 , 221. 
68. F. Bosca, M. A.Miranda. J. Pholochem. Photoblo. B: Bio. 43. 1998, 1-26. 
69. D. E. Moore, J. Wang, J. Photochem. Photobiol. B-Biol 1998, 43, 175. 
70. F .Vargas H. Mendez , A. Fuentes , J. Sequera , G. Fraile , M .Velasquez, G. 
Caceres , K.Cuello, Pharmazie. 2001, 56, 83. 
71. J. S. Poole, C. M. Hadad, M. S. Platz, Z. P. Fredin, L. Pickard, E. Lev>a 
Guerrero, M. Kessler, G. Chowdhury, D. Kotandeniya, K. S. Gates. 
Photochem.Photobiol, 2002, 75, 339. 
72. F. Vargas, C. Rivas, A. Fuentes, A. T. Cheng, G. Velutini, J. Photochem. 
Photobiol. A-Chem, 2002,153, 237. 
73. T. Iwamoto, Y. Hiraku, M. Okuda, S. Kawanishi, Pharmaceut Res, 2008. 25. 
598. 
74. V. Brezova, M. Valko, M. Breza, H. Morris, J. Telser, D. Dvoranova. K. 
Kaiserova, L. Varecka, M. Mazur, D. Leibfritz, J. Phys. Chem. B. 2003, 107, 
2415. 
75. R. Arce, C. Garcia, R. Oyola, L. Pinero, I. Nieves , N. Cruz, , J. Photochem. 
Photobiol. A-Chem,2003,154, 245. 
76. C. Garcia, L. Pinero, R. Oyola, R. Arce, photochem. photobiol. 2009; 85(1), 
160-170. 
77. G. Xia, Wu Longmin, Yang Li, Liu Youcheng and Liu Zhongli, Science in 
chain (series B), vol. 42 No. 2, April 1999. 
Page V 
78. F. Bosca, P. Morliere, M. A. Miranda, J. V. Castelle and R. Santus; 
Photochem. Photobiol. ScL, 2006, 5, 336-342. 
79. F. Bosca, P. Morliere, M. A. Miranda, J. V. Castelle and R. Santus; 
Photochem. and Photobiol., 2004, 80, 535-541. 
80. F. Vargas, I. M. Volkmar, J. S. H. Mendez, J. Rojas, G. Fraile, M. 
Velasquez, R. Medina, J. Pholochem Pholobiol B- Biol, 1998, 42, 219. 
81. F. Vargasa, M. V. Hisbeth, J. K. Rojas, J. Photochem. Photobiol. A-Chem, 
1998,118, 19. 
82. A. Gupta, J. Iqbal, W. Ahmad, M. R. Zaheer, Journal of taibah; 2014, 8(1), 64-
70. 
83. Thesis, M. R. Zaheer, 2012, A.M.U. Aligrarh. 
84. F. Vargas, C. lzzo,T. Zoltan,V. Lopez, Avarices in Quimica, 2006, 3, 3. 
85. W. Zhou, D. E. Moore, J. Photochem. Photobiol. B-Biol, 1997, 39, 63. 
86. E. Lemp, C. Valencia, A. L. Zanocco, J. Photochem. Photobiol. A-Chem, 
2004,168,91. 
87. S. Caffieria, S. D. Acqua, I. Castagliuolo, P. Brunb, G. Mioloa., J.Pharm. 
Biomed. Anal, 2008, 47, 771. 
88. K. Jochym, H. Barton, J. Bojarski, Pharmazie, 1988, 43, 623. 
89. S. Sortino, S. Giuffrida, J. C. Scalane, Chem. Res. Toxicol. 1999, 12, 971. 
90. S. Sortino,S. Petralia,F. Bosca ,M. A. Miranda, Photochem. Photobiol. Sci., 
2002,1, 136. 
91. S. Montanaro, V. Lhiaubet-Vallet, M. R. lesce, L. Previtera, M. A. Miranda, 
Chem. Res. Toxicol. 2009, 22, 173. 
92. G. Viola, P. Grobelny, M. A. Linardi, A. Salvador, G. Basso, J. Mielcarek,S. 
D. Acqua, D. Vedaldi, F. Dall'Acqua, Toxicol Sci, 2010,118, 236. 
Page vi 
93. B. Heyne, S. Kohnen, D. Brault, A.Mouithys-Mickalad, F. Tfibel, P. Hans. M. 
F. Aupart, M. Hoebeke, Photochem. Photobiol. Sci., 2003, 2, 939. 
94. P. J. Bilski, M. A. Wolak, V. Zhang, D. E. Moore, C. F. Chignell, Photochem. 
Photobiol, 2009, S5,U27. 
95. F. Vargas, C. Rivas, A. Fuentes, A. T. Cheng, G. Velutini, J. Photochem. 
Photobiol. A-Chem, 2002,153, 237. 
96. F. Bosca, M. C. Cuquerella, M. L. Marin, M. A. Miranda, Photochem 
Photobiol.,200\,73,463. 
97. N. Canudas, C. Contreras, Pharmazie. 2002, 57, 405. 
98. M. DellaGreca, M. Rosaria lesce, L. Previtera, M. Rubino, V. Barone, O. 
Crescenzi, J. Photochem. Photobiol. A-Chem, 2008,199, 353. 
99. Thesis, W. Ahemad, 2012, A.M.U. Aligrarh. 
100. F. Vargas, C. Rivas, A. Fuentes, A. T. Cheng, G. Velutini, J. Photochem. 
Photobiol. A-Chem, 2002,153, 237. 
Page vii 
Chapter 2 
Photochemical Studies on 
Photosensitizing Drugs Triflupromazine 
and Quetiapine 
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Introduction 
Probably because of the frequent exposure to sunlight typical of today's lifestyle, 
photoinduced adverse side-effects caused by drugs that absorb significantly natural or 
artificial light are a matter of growing concern. As a consequence, the photochemical 
properties of drug molecules are investigated in order to provide a rationale for the 
observed effects ' . Recently great interest has been shown in the mechanisms of 
degradation of photosensitizing drugs that induced photosensitization disorders such 
as photomutagenic, photocarcinogenic, photoallergy and phototoxicicity^''* and that 
are widely used in the clinical practice. There are large numbers of photosensitizing 
drugs of varied structural variety and significant variations in the photosensitization 
mechanisms must be expected depending on the difference in structural features. 
This, together with the limited research effort devoted to this subject so far, means 
that for most photosensitizing /phototoxic drugs a relationship between structure and 
in vitro/ in vivo photoreactivity is not available. Hence, the dated interest of 
photochemists in the properties of the electronically excited states of compounds of 
pharmaceutical use has been rapidly increasing during the last decade^' . 
It has been noted that chemically there are two main types of photosensitization 
mechanisms caused by excited sensitizer: Type I (direct radical mediated-reactions) 
and Type II (singlet oxygen-mediated reactions). Many important photosensitization 
reactions are Type I processes, and the radical produced via electron transfer process 
in photosensitization reactions has been reported for some important class of drugs 
including, flouroquinolone^ NSAID^, Phenothiazine^, l-4-dihydropyridin'°, 
vasoreguiator" have been highlighted in recent publication. Photo-initiated electron 
transfer reactions in drugs are receiving considerable attention recently also fi-om a 
more fiindamental photochemical standpoint'^. With this interest herein we have 
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investigated the photochemical behavior of triflupromazine and quetiapine under 
different reaction conditions. In this study, our goal was to characterize the 
photochemical properties of these drugs in order to understand and rationalize the 
mechanisms of photodegradation which may be helpful to understand the mechanism 
of photosensitization. The photophysical properties of these drugs were also measured 
in several solvents to investigate the relevance of the molecular structure in their 
photophysics and consequent photochemistry. Because the interaction modes of each 
drug and its corresponding species strongly depend on the variety of 
microenvironments, their properties shall also be determined separately to understand 
fully the mechanism of drug degradation and the mechanism of its side effects. 
[A] Electron-Transfer Mechanism in the Photodegradation of Phototoxic Drug 
Triflupromazine. 
[B] Electron-Transfer Mediated Photodegradation of Phototoxic Antipsychotic 
Drug Quetiapine. 
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Section [A] 
Electron-Transfer Mechanism in the 
Photodegradation ofPhototoxic Drug 
Triflupromazine 
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[A] Electron-Transfer Mechanism in the Photodegration of Phototoxic Drug 
Triflupromazine. 
Triflupromazine (TPZ, 1) is a new antipsychotic drug belonging to the phenothiazine 
class of compound endowed with dopamine D1/D2 receptor antagonistic activities in 
the central nervous system (CNS), and is commonly used as part of anti-psychotic 
medication'^. Phenothiazine drugs widely used for treatment of serious mental, 
psychotic and emotional disorders, including schizophrenia and organic psychoses the 
manic phase of manic-depressive illness. The acute or chronic idiopathic psychotic 
illnesses of TPZ are divided into the aliphatic side chain, piperazine, piperidine 
subclasses, based on differences in their chemical structure and exhibit different 
pharmacological actions and potency' . Promazines, piperidines, and perazines are 
derivatives of phenothiazine and belong to the most commonly used families of 
tricyclic antidepressant drugs in the treatment of mental illness'^. Phenothiazine and 
its derivatives are also cytostatic and/or cytotoxic in a variety of non-CNS cells"'. It 
reduces anxiety, emotional withdrawal, hallucinations, disorganized thoughts, blunted 
mood, and suspiciousness . 
The substituent's which were attached to the position C-2 of the tricyclic 
phenothiazine ring and the length of the alkyl bridge connecting the nitrogen atom at 
position 10 (N-10) of the tricyclic ring, with the terminal amine group in the side 
chain, determine activity of phenothiazine derivatives against cancer cells and the 
activity is more strongly bound to the type of substituent's in the phenothiazine ring 
than by the nature of the side chain'^ Phenothiazine ring modifications gave the 
derivatives (e.g., benzo[a]phenothiazines, azaphenothiazines) with marked anticancer 
and antibacterial activity on various cell lines in order to gain insight into the 
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structural-activity '^'^°. Besides these effect of TPZ (1) has also been reported to show 
phototoxic as an adverse side effect"^  ^  This has stimulated to study the photochemical 
behavior of it with the aim to establish the target for the phototoxic effect and the 
chemical reactions occurring. In the present study, we have, here investigated the 
photochemical behavior of TPZ (1) in the presence of electron donor, N,N-
Dimethylaniline (DMA) and electron acceptor, 1,4-Dicynonbenzene (DCB) in UV-
light under anaerobic condition with the aim of isolation, identification of its 
photoproducts and elucidation the photoinduced electron transfer mechanism, and a 
detailed knowledge of the photophysical and photochemical properties of a 
photosensitizing drugs is obviously essential to understanding of its mechanism of 
action in biological system. In this connection, photodegradation of triflupromazine 
may have significance in rationalized the observed phototoxicity of this drug. 
MA TERIALS AND METHODS 
Materials and chemicals 
All chemicals used were of analytical grade. Triflupromazine (TPZ) hydrochloride 
was purchased from (Unicure, India, Pvt. Ltd.), N, N-dimethylaniline (DMA) and 1, 
4-dicyanonbenzene (DCB) was purchased from Sigma Aldrich (India). The authentic 
purity of drug sample was determined by M.P., ' H - N M R , and HPLC (94.68%). 
APPARATUS 
Irradiation were carried out in photochemical reactor equipped with medium pressure 
mercury vapor lamp (Philips, 450 W) inserted in water cooled immersion well with 
continuous supply of water. IR spectra were recorded in KBr discs on a Perkin Elmer 
model spectrum RXI. HPLC spectra were recorded on Ultra high performance liquid 
chromatography (UHPLC system). 'H-NMR and '^C-NMR spectra were recorded on 
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a Bruker Avance-400 MHz NMR spectrometer, DMSO-De as a solvent. Mass spectra 
were determined with a LC-ESI/APCT triple mass spectrometer. Column 
chromatography was performed on silica gel 60-120 mesh; TLC was carried on 
Merck silica gel 60 F254 (0.2 mm thick plates). UV absorbance spectra were performed 
on double beam Shimadzu UV1800 Spectrophotometer (Shimadzu, Kyoto, Japan) 
equipped with 150-W deuterium lamp and fluorescence spectra were recorded on 
Hitachi F-2500 (Hitachi, Tokyo, Japan) spectrophotometer equipped with 150-W 
Xenon lamp, using a quartz cell of 1.0 cm path length. The Width of both the 
excitation slit and emission slit were set at 5.0 nm and 10.0 nm. 
General Photoirradiation procedure 
A solution of TPZ (1) in methanol was stirred for 5-6 h before irradiation and was 
kept bubbling during the irradiations. The course of reaction was monitored by thin 
layer chromatography on pre-coated silica gel TLC plates using chloroform-methanol 
(92:08) mixture. After the completion of reaction (when desired conversions have 
reached) the solvent was removed in a rotary evaporator and products were purified 
by silica gel colunrn chromatography. 
Irradiation of TPZ in presence of DMA under anaerobic condition 
A solution of TPZ (1) (500mg, 0.5 mM) was dissolved in 500 ml of methanol and was 
irradiated at 310 nm in presence of three mole equivalents of electron donor . N, N-
Dimethylaniline (DMA) with continuous stirring at 30-40°C for 5-6 hour under Nj 
atmosphere. After following the steps as described in the general photoirradiation 
procedure, the photoproducts 2 and 3 were obtained which exhibit the following 
spectral properties. 
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Dimethyl-(3-phenothiazm-10-yl-propyl)-amine (2); Yield: 50 mg (10%); UV l^U 
MeOH) 244 nm(s), 265 nm(w); HRMS calcd. for ( M^) C17H20N2S 284.4191, found 
284.1347; IR (KBr/cm-') 3043, 2965, 1585, 1502, 1468, 1384, 1296, 1276, 1212, 
1049, 978, 766; ' H - N M R (DMS0-d6, 400 MHz) 5 6.682 ( t , 2H, Ar.), 6.918 (m, 4H, 
Ar.), 6.996( m, 2H, Ar.), 3.062 ( t , J=7.2 Hz, 2H, 11), 2.363 (t, J=6.8 Hz, 2H, 13), 
2.274 ( s ,6H, 15, 16), 1.624 ( m, J=7.0 Hz, 2H,12) ppm; '^C-NMR (DMSO-dg, 400 
MHz) 5 145.7, 131.9, 127.9, 121.2, 118.6, 118.5, 56.3, 55.7, 41.5, 28.3 ppm; MS: 
m/z: 284 (M^), 270 (M^-14), 256 (M^-28), 199 (M^-85). 
[3-(2-Methoxy-phenothiazin-10-yl)-propyl]-dimethyl-amine(3); Yield: 90 mg (18%); 
UV >^ ax (MeOH) 260 nm(s), 230 nm(w); HRMS calcd. for ( M^ ) C18H22N2OS 
314.4451, found 314.1453; IR (KBr/cm'') 3054, 3028, 2950, 1598, 1490, 1386, 1298, 
1247 (asym. C-O-C), 1205, 1054, 1040 (sym. C-O-C), 978, 767; ' H - N M R ( D M S O -
d6, 400 MHz) § 7.012 (m, 4H, Ar.), 6.80 (d, IH, Ar.), 6.26 (d, IH, Ar.), 6.19 (s, IH, 
Ar.), 3.738 ( s, 3H, 17 ), 3.068 ( t, J=7.2 Hz, 2H,11), 2.366 (t, J=6.4 Hz, 2H, 13), 
2.276 (s, 6H,15,16), 1.628 (dd, J=7.2 Hz, 2H, 12) ppm ; '^C-NMR (DMS0-d6, 400 
MHz) 5 161.4, 146.7, 145.7, 132.9, 131.9, 127.9, 121.2, 118.6, 118.5, 113.5, 104.2, 
104.1, 56.3, 56.0, 55.7, 41.5, 28.3 ppm; MS: m/z: 314 (M^), 299 (M^-15), 298 (M^-
16),228(M^-76). 
Irradiation of TPZ in presence ofDCB under anaerobic condition 
A solution of TPZ (1) (500mg, 0.5 mM) was dissolved in 500 ml of methanol and was 
irradiated at 254 rmi in presence of three mole equivalents of electron acceptor ^^  1,4-
dicyanobenzene (DCB) with continuous stirring at 30-40°C for 5-6 hour under N2 
atmosphere. After following the steps as described in the general photoirradiation 
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procedure, the photoproducts 4 and 5 were obtained which exhibit the following 
spectral properties. 
3-(2-Trifluoromethyl-phenothiazin-10-yl)-propionaldehyde (4); Yield: 120 mg 
(24%); UV X^ ax (MeOH) 240 nm(s), 268 nm (w); HRMS calcd. for (M^) 
C16H12F3NOS 323.3328, found 323.0592; IR (KBr/cm-') 3044, 3026, 2980, 2950, 
1745 (C=0), 1598 (C=C), 1490, 1470, 1384, 1298, 1205, 1054, 978, 767; ' H - N M R 
(DMS0-d6, 400 MHz) 8 9.724 ( s, IH, 13), 7.012-6.668 ( m, 7H, Ar.), 3.392 ( t, 
J=7.8 Hz, 2H, 11), 2.634 (t, J-7.8 Hz, 2H, 12) ppm; '^C-NMR (DMSO-de, 400 MHz) 
6 200.6, 146.0, 145.7, 132.2, 131.9, 130.4, 127.9, 124.5, 121.2, 119.3, 118.6. 118.5. 
115.4, 115.3, 50.2, 42.8 ppm; MS: m/z: 323 (M^), 294 (M^-29), 254 (M"-69). 199 
(M^-124). 
MethyI-[2-(2-trifluoromethyl-phenothiazin-10-yl)-ethyI]-amine (5); Yield: 100 mg 
(20%); UV >tmax( MeOH) 242 nm(w), 256 nm(s); HRMS calcd. for ( M" ) 
C17H17F3N2S 338.3639, found 338.0908; IR (KBr/cm"') 3428 (N-H), 3044, 3026, 
2980, 1598, 1490, 1384, 1296, 1249, 1205,1024, 978, 768; ' H - N M R (DMSO-de. 400 
MHz) 6 7.012-6.668 ( m,7H, Ar.), 3.068 ( t , J=7.2 Hz, 2H, 11), 2.554 ( t , J=6.8 Hz. 
2H, 13), 2.472 ( s , 3H, 15), 2.202 ( s, br., IH, 14), 1.642 ( dd, J=7.0 Hz, 2H, 12) ppm 
; '^C-NMR (DMSO-de, 400MHz) 6 146.0, 145.7, 132.2, 131.9, 130.4, 127.9. 124.5. 
121.2, 119.5, 118.6, 118.5, 115.4, 115.3, 55.4, 49.4, 33.2, 30.8 ppm; MS: m/z: 338 
(M^), 308 (M^-16), 293 (M^-29), 253 (M^-69), 200 (M^-124). 
Results and Discussion 
When irradiation of Triflupromazine, (TPZ, 1) was carried out under anaerobic 
condition at 310 nm in the presence of electron donor, N, N-dimethylaniline (DMA) 
in a photochemical reactor equipped with medium pressure mercury vapor lamp. It 
afforded two major photoproducts 2 and 3. When irradiation of TPZ (1) was carried 
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out in the presence of electron acceptor (DCB) under the similar condition, it afforded 
the photoproducts 4 and 5. These photoproducts were isolated and characterized on 
the basis of their spectral (IR, ^H-NMR, '^C-NMR, UV and MASS spectra) 
properties. The assigned structure to these products well corresponds to their observed 
spectral properties. All the products obtained by photoirradiation of triflupromazine, 
(TPZ, 1), were characterized on the basis of following spectral evidences. The ' H -
NMR and '^C-NMR spectrum of compound 2 were similar to those of 1 except for the 
signals obtained due to trifluorodemethylation. ' H - N M R at 5 6.996 ppm clearly 
indicated the removal of CF3 group. '^C-NMR signal corresponding to (C-2) was 
slightly deshielded to appear at 8 127.9 ppm indicated the removal of CF3 This was 
confirmed by X,max at 244.0 nm. The compound was thus assigned structure as 2 with 
a molecular formula C17H20N2S (M"^ , 284). 
IR band at 1040 cm '^ (sym. C-O-C), ' H - N M R signal at 5 3.738 ppm and ^^C-NMR 
signal at 5 56.0 ppm indicated the presence of phenolic methoxy group in the aromatic 
ring. The 'H-NMR signals for H-1, H-3 and H-4 were highly shielded to appear at 5 
6.19, 6.26 and 6.80 ppm, respectively. The '^C-NMR signals for C-2, C-4 were 
deshielded to appear at 5 161.4, 132.9 ppm, while signals for C-1, C-3 were highly 
shielded to appear at 5 104.1, 104.2 ppm, indicated the presence of methoxy at C-2 
position. This was also supported by Xmax. at 260 nm. The compound was thus 
assigned structure as 3 with a molecular formula C18H22N2OS (M *, 314). The 
formation of the photoproducts has been rationalized through photoinduced 
intermolecular electron transfer mechanism under anaerobic condition as given in 
Scheme 2A. 1. 
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The mechanism of photoproduct 2 and 3 can be rationalized when the irradiation 
leads to the electronic excited state of triflupromazine 1. The excited state of TPZ 
accept an electron from the ground state molecule of electron donor (DMA) to form 
corresponding radical anion (TPZ'~) and radical cation (DMA* "^). Subsequently. 
the generated radical anion (TPZ* ) that undergoes an intermolecular electron 
transfer mechanism, it afforded the corresponding photoproducts 2 and 3. The outline 
mechanism in scheme 2A. 1 well explains the observed reaction. 
^ ^ ^ ^ N ^ ' ^ ^ ^ C F , N2 DMA 
R' 
(1) 
» 1 ^ , R'=(CH2)3N(CH3)2 
T ^ 
N 
R> 
CF3 DMA 
I "CFa+H'-^CHFj 
-^ 
-^ N 
R' 
CH3OH 
ot-H abstration 
V - ^ V ^ 
. ^ n 
R' 
(2) 
R' 
(3) 
O CH3 
Scheme 2A.1: Mechanistic pathways for the photodegradation of TPZ in presence of 
DMA under anaerobic condition. 
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When irradiation of TPZ (1) was performed in the presence of electron acceptor 
(DCB) under the similar condition, it afforded the photoproducts 4 and 5. The 
structure of the photoproducts 4 and 5 were confirmed on the basis of their spectral 
(IR, ' H - N M R , ' ^C-NMR, U V and MASS spectra) properties. The ^H-NMR and '^C-
NMR spectrum of compound 4 were similar to those of 1 except for the signals 
obtained due to aliphatic side-chain. A sharp IR absorption band at 1745 cm"' (>C=0) 
indicated the presence of carbonyl functional group. ' H - N M R signal at 6 9.724 (s, 
IH) ppm and '^C-NMR signal at 6 200.6 (C-13) ppm, clearly indicated the presence of 
aliphatic aldehydic functional group. The ' H-NMR signal for H-11 and H-12 were 
deshielded to appear at 5 3.392, 2.634 ppm, removal of dimethylamine signals 
suggested the tertiary amine functional group convert into aldehydic functional group. 
This was confirmed by >Lmax at 240 nm. The compound was thus assigned structure 
as 4 with a molecular formula C16H12F3NOS (M"^, 323). 
A sharp IR absorption band at 3428 cm'' (N-H), a broad ' H - N M R signal at 6 2.202 
ppm, indicated the presence of secondary amine functional group. The ' H-NMR 
signal for H-12, H-13 and H-15 were slightly deshielded to appear at 8 1.642, 2.554 
and 2.472 ppm, respectively. While '^C-NMR signal for C-13 and C-15 was highly 
shielded to appear at 6 49.4, 33.2 ppm suggested the formation of secondary amine 
functional group in the aliphatic side-chain and removal of CH3 signal at 5 41.5 ppm 
from 5, indicated the formation of N-demethylated product. This was confirmed by 
>.max at 242 nm. The compound was thus assigned structure as 5 with a molecular 
formula C17H17F3N2S (M^ 338). 
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A plausible mechanism for the observed reaction involves a photoinduced 
intermoleculer electron transfer between the photoexcited TPZ (1) and ground state of 
DCB afforded the formation of the radical cation (TPZ' "•") and radical anion (DCB' ~ 
). Subsequently, the generated triflupromazine radical anion (TPZ' ~^) undergo 
hydrolysis of imine (>C=N) afforded the corresponding photoproducts 4 and 5. The 
above obtained results are the good agreement with the mechanism, depicted in 
scheme 2A.2. 
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Scheme 2A.2: Mechanistic pathways for the photodegradation of TPZ in presence of 
DCB under anaerobic condition. 
Page 79 
Photophysical Properties 
Effect of the concentration ofphotoproducts on the absorption intensity 
Fig. 2.1 a-d represents the absorption spectra of the photoproduct 2-5 on continuous 
increasing the molar concentration in the ranges of 220-320 nm. The spectra of the 
photoproducts are different from the parent drug molecule, suggested the formation of 
new photoproducts. From the figure, it is clear that the peak intensity of the 
photoproducts increases with increasing the concentration of photoproducts, there is 
no shift in the absorption maxima and the nature of the absorption profile remains 
almost constant shown in Fig. 2.1 a-d. 
Effect of concentration of photoproducts on fluorescence spectral intensity 
The fluorescence spectra of the molecules deal with the excited state of 
photoproducts. The spectra of the photoproducts 2-5 were carried out with continuous 
increasing the molar concentration of compound at a fixed excited wavelength of the 
molecule in the range of 550-650 nm. From the figure, it is clear that the peak 
intensity of photoproducts increases by about 10 times on increasing the concentration 
of the photoproducts. The photoproducts 2, 3, 4 and 5 were excited at different 
wavelengths 244, 260, 240 and 242 nm, respectively. The fluorescence intensity vs. 
wavelength plots of the photoproducts is showoi in Fig. 2.2a-d. 
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In conclusion, our findings shows that triflupromazine (1) undergoes photochemical 
transformation in the presence of both electron donor (N, N-dimethylaniline) and 
electron acceptor (1, 4-dicyanobenzene) under anaerobic condition in UV light 
through photoinduced electron transfer mechanism. The importance of the 
photophysical studies is that at higher concentration photoproducts, it absorbs a large 
fraction of light radiation and the excited state of the molecule may interact with the 
biological system and the photoproducts may undergoes further dissociation 
mechanistic pathways in presence of UV light. On the basis of obtained results, it is 
clear that the electron transfer plays a significant role in the photodegradation of 
triflupromazine. The involvement of radical ions may account for the phototoxic 
effects, sometime observed, in therapeutic uses of the drug. Therefore, the obtain data 
confirmed that the adequate light protection should be adopted for the handling and 
storage of triflupromazine and it suggested that excessive sunlight should be avoided 
after the drug consumption. 
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[B] Electron-Transfer Mediated Photodegradation of Phototoxic Antipsychotic 
Drug Quetiapine 
Quetiapine is a short-acting atypical or second generation antipsychotic (SGAs) drug 
belonging to the class of dibenzothiazepines approved for the treatment 
of schizophrenia, bipolar disorder and along with an antidepressant to treat major 
depressive disorder during last half of 20th century '^*'^ ^ Quetiapine is an antagonist of 
a broad range of neurotransmitter receptors^^ Out of various antipsychotic drugs, 
there are three basic classes of medications such as conventional, atypical and 
dopamine partial agonist antipsychotics drugs which act principally on dopamine 
systems^^" '^. Specifically the Dl, D2 dopamine, the a 1, a 2 adrenoreceptor and 5-
HTIA, 5-HT2 serotonin receptor subtypes are antagonized. Quetiapine fumarate also 
has an antagonistic effect on the histamine HI receptor. It has no significant affinity 
for cholinergic muscarinic or benzodiazepine receptors. Drowsiness and orthostatic 
hypotension associated with use may be explained by its antagonism of histamine HI 
and adrenergic a 1 receptors, respectively^^. 
Quetiapine drug is well tolerated and characterized by fewer extrapyramidal 
symptoms (EPS) than the conventional antipsychotic drugs and it is also effective in 
hard to treat patients . Quetiapine is a phototoxic drug and the photodegradation of 
drugs may loss the activity of a drug and also in adverse effects due to the formation 
of toxic degradation products '^*'^ ^ Phototoxic effect can appear in any patient rovided 
hat his skin is under exposed to enough light doses and the photosensitizer is present 
at the appropriate concentration. Usually, these reactions appear immediately after the 
first exposure of UV-light and are confined to the exposed areas of the skin^ '^^ .^ 
Quetiapine and a large number of drug molecules absorb radiation in the ultraviolet 
and/or visible region and are thus shows a photosensitivity towards the UV-light 
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radiation^^"^\ In continuation of our research interest in the present study, we have, 
here investigated the photochemical behavior of QTP (6) in the presence of electron 
donor, N,N- Dimethylaniline (DMA) and electron acceptor, 1,4-Dicynobenzene 
(DCB) in UV-light under anaerobic condition with the aim of isolation, identification 
of its photoproducts and elucidation of molecular mechanism. In the photodissociative 
study of the drug, a detailed knowledge of the photophysical and photochemical 
properties of photosensitizing drugs is obviously essential to understanding of its 
mechanism of action in biological system. In this connection, photodegradation of 
quetiapine may have significance in rationalized the observed phototoxicity of this 
drug. Irradiation of methanolic solution of QTP (6) in the presence of electron donor 
(DMA) under anaerobic condition results in the formation of one major photoproduct 
7. When it was irradiated in the presence of electron acceptor (DCB) under the same 
condition photoproduct 8 was obtained. Which were isolated and identified from their 
spectral (IR, ' H - N M R , ' ^C-NMR, and Mass spectra) properties. Formation of the 
photoproducts 7 and 8 were explained by photoinduced electron transfer mechanism. 
MATERIALS AND METHODS 
Materials and chemicals 
All chemicals used were of analytical grade. Quetiapine fumarate (QTP) was 
purchased from (Sun Pharmaceutical Industries Ltd., Mumbai, India), N, N-
dimethylaniline (DMA) and 1, 4-dicyanonbenzene (DCB) were purchased from 
Sigma Aldrich (India). The authentic purity of drug sample was determined by M.P., 
IH-NMR, and HPLC (92.18%). 
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APPARATUS 
Photochemical reaction was carried out in a quartz fitted immersion well 
photochemical reactor equipped with 400W medium pressure mercury vapour lamp 
with continuous supply of water. IR spectra were recorded in KBr discs on a Perkin 
Elmer model spectrum RXI. HPLC spectra were recorded on Ultra high performance 
liquid chromatography (UHPLC system). ' H - N M R and '^C-NMR spectra were 
recorded on a Bruker Avance-400 MHz NMR spectrometer. Mass spectra were 
determined with a LC-ESI/APCT triple mass spectrometer. Column chromatography 
was performed on silica gel 60-120 mesh; TLC was carried on Merck silica gel 60 
F254 (0.2 mm thick plates). UV absorbance spectra were performed on double beam 
Shimadzu UV1800 Spectrophotometer (Shimadzu, Kyoto, Japan) equipped with 150-
W deuterium lamp and fluorescence spectra were recorded on Hitachi F-2500 
(Hitachi, Tokyo, Japan) spectrophotometer equipped with 150-W Xenon lamp, using 
a quartz cell of 1.0 cm path length. The Width of both the excitation slit and emission 
slit were set at 5.0 nm and 10.0 rmi. 
General Photoirradiation procedure 
An alcoholic solution of Quetiapine (QTP, 6) was irradiated for 5-6 h before 
irradiation and was kept bubbling during the irradiations. The course of reaction was 
monitored by thin layer chromatography on pre-coated silica gel TLC plates using 
chloroform-methanol (94:06) mixture. After the completion of reaction (when desired 
conversions have reached) the solvent was removed in a rotary evaporator and 
products were purified by silica gel column chromatography. 
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Irradiation ofQTP in presence of DMA under anaerobic condition 
A methanolic solution of QTP (6) (1.0 gm, 0.5 mM) was irradiated at 254 nm in 
presence of 2.5 mole equivalents of electron donor'*'^ '''^  (DMA) with continuous 
stirring at 30-40°C for 5-6 hour under N2 atmosphere. After following the steps as 
described in the general photoirradiation procedure, the photoproduct 7 was obtained 
which exhibit the following spectral properties. 
2-{2-[4-(10,11-Dihydro-dibenzo [b,f][l, 4] thiazepin-ll-yl)-piperazin-l-yl]-ethoxy} 
ethanol (7); Yield: 50 mg (5.0%); UV ?^ a^x (MeOH) 280 nm (w); HRMS calcd. for 
(M^) C21H27N3O2S 385.5230, found 385.1824, IR ( KBr/cm-') 3445 (s, N-H), 3310 
(br., 0-H), 3045, 3012, 2980, 2950, 1478, 1365, 1212, 978, 818, 764; ' H - N M R 
(DMSO-de, 400MHz) 6 6.823 (d, IH, J=8.0, Ar-H), 7.112 (m, IH, Ar-H), 7.208 (d, 
IH, J=7.6, Ar-H), 7.228-7.434 (m, 4H, Ar-H), 7.508 (m, IH, Ar-H), 5.048 (s, IH, 11), 
4.024 (br., s, N-H, 10), 3.702 (t, 2H, 20), 3.568 (t, 2H, 19), 3.454 (t, 2H, 17), 2.534 (t, 
2H, 16), 2.468-2.548 (m, 8H,13,13',14,14'), 2.122 (s, IH, 21) ppm; ^^C-NMR 
(DMSO-d6,400MHz) 5 146.4, 138.2, 132.3, 132.0, 131.2, 130.8, 129.8, 127.9, 127.7, 
126.5, 115.8, 112.6, 72.8, 67.3, 60.3, 56.8, 52.4 ppm; MS: m/z: 386 (M^+1), 385(M^), 
322(M^-63),211(M^-174). 
Irradiation of QTP in presence ofDCB under anaerobic condition 
A methanolic solution of QTP (6) (1.0 g, 0.5 mM) was irradiated at 310 nm in 
presence of 2.0 mole equivalents of electron acceptor'*'^ ''*^ (DCB) with continuous 
stirring at 30-40°C for 5-6 hour under N2 atmosphere. After following the steps as 
described in the general photoirradiation procedure, the photoproduct 8 was obtained 
which exhibit the following spectral properties. 
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N'-Dibenzo [bj][l,4] thiazepin-ll-yl-N^-ethyl-ethane-l,2-diamine (8); Yield: 38 
mg (3.8%); UV 7^^ (MeOH) 246 nm (s); HRMS calcd. for (M^) C17H19N3S 
297.4179, found 297.1300, IR (KBr/cm'') 3445, 3226 (s, 2 N-H), 3030, 3010, 1648 
(>C=N), 1415, 1337, 1308, 1256, 970, 838, 794, 765; ^H-NMR (DMSO-dg, 400MHz, 
ppm) 5 7.554 (m, IH, Ar-H), 7.254-7.402 (m, 4H, Ar-H), 7.204 (d, IH, J=7.6, Ar-H), 
7.102 (m, IH, Ar-H), 6.854 (d, IH, J=8.0, Ar-H), 2.814 (t , 2H, J=6.4, CHj), 2.772 (t, 
2H, J=6.4, CH2), 2.598 (q, 2H, J=6.8, CH2), 2.122 (s, 2H, NH2), 1.058 (t, 3H, J=6.8, 
CH3) ppm; '^C-NMR (DMSO-de, 400MHz) 8 164.4, 156.7, 135.4, 132.3, 131.1, 
130.5, 129.2, 128.3, 127.6, 127.1, 126.5, 125.3, 122.6, 51.8, 42.1, 40.5, 13.8 ppm; 
MS: m/z: 298 ( M V I ) , 297 (M*), 296 (M^-1), 281 (M^-16), 211 (M^-86). 
RESULTS AND DISCUSSION 
Irradiation of quetiapine, (QTP, 6) was carried out under anaerobic condition at pH= 
4.0 in the presence of electron donor at N, N-dimethylaniline (DMA) in a 
photochemical reactor equipped with medium pressure mercury vapor lamp at 254 
nm. It afforded one major photoproduct 2-{2-[4-(10, 11-Dihydro-dibenzo [b, f| [1, 4] 
thiazepin-ll-yl)-piperazin-l-yl]-ethoxy} ethanol (7), The photoproduct was isolated 
and identified from their spectral (IR, ^H-NMR, '^C-NMR, and Mass spectra) 
properties. The assigned structure to these products well corresponds to their observed 
spectral properties. The ' H - N M R and '^C-NMR spectrum of compound 7 were 
similar to those of 6 except for the signals obtained due to dibenzothiazepines ring. IR 
absorption band at 3445 cm'' (s, N-H), a broad ^H-NMR signal at 5 4.024 (br., s, N-H) 
ppm indicated that the secondary amine functional group. A sharp H-NMR signal for 
H-n to appear at 5 5.048 ppm and its corresponding '^C-NMR signal appear at 5 70.6 
ppm indicated that the imine functional group converted into secondary amine 
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product. This was also supported by X^ ax at 280 run. The compound was thus assigned 
structure as 7 with a molecular formula C21H27N3O2S (M ,^ 385). The mechanistic 
pathway for the formation of compound 7 is outlined in Scheme 2B.1. 
hradiation of QTP (6) in the presence of electron donor (DMA) under anaerobic 
condition gave the photoproduct 7. The photoinduced electron transfer mechanism of 
7 can be rationalized when irradiation leads to the electronic excited state of QTP (6). 
The excited state of QTP accept an electron from the ground state of electron donor 
(DMA) molecule form corresponding radical anion (QTP* ) and radical cation 
(DMA* "•"). Subsequently, the generated quetiapine radical anion (QTP* ) undergoes 
photoinduced electron transfer mechanism by abstraction of H atom from the solvent 
molecule followed by hydrolysis to yield photoproduct 7. The outline mechanism in 
scheme 2B.1 well explains the observed reaction. 
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Scheme 2B.1: Mechanistic pathways for the photodegradation of QTP in presence of 
DMA under anaerobic condition. 
When QTP (6) was irradiated at 310 nm in presence of DCB under anaerobic 
condition, it afforded the corresponding product 8. The structure of the photoproduct 
was confirmed on the basis of their spectral (IR, ' H - N M R , ' ^ C - N M R , U V and mass 
spectra) properties. The H-NMR and C-NMR spectrum of compound 8 were 
similar to those of 6 except for the signals obtained due to aliphatic side chain. Two 
sharp single IR absorption band at 3445, 3226 cm"' (s, 2N-H) and a broad ' H - N M R 
signal at 5 2.122 (s, 2H, NH2) ppm indicated that the presence of primary amine 
functional group. The signals due to piperazine ring were highly affected to appear at 
8 2.592 and 2.772 for H-13, H-15, respectively. While '^C-NMR for C-13 and C-15 
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appears at 5 40.5, 51.8 ppm indicated the cleavage of piperazine ring. A more 
characteristic NMR signal for H-14 at 6 1.058 ppm and C-14 at 8 13.8 ppm indicated 
the formation of CH3 group in the piperazine ring and other signals due to aliphatic 
side chain was missing from 8. This indicates that the piperazine ring was cleaved 
through the photoinduced electron transfer mechanism. This was also confirmed by 
Xmax at 246 nm. The compound was thus assigned structure as 8 with a molecular 
formula C17H19N3S (M^ 297). 
A plausible mechanism for the observed reaction involves a photoinduced 
intermoleculer electron transfer between the photoexcited state of QTP (6) and the 
ground state of electron acceptor (DCB) molecule. It afforded the formation of the 
radical cation (QTP"^) and radical anion (DCB'~). Subsequently, the generated 
quetiapine radical cation (QTP' "•") undergoes the hydrolysis of imine (>C=N) in the 
alcoholic solvent and a back electron transfer to afforded the corresponding 
photoproduct 8. The above results obtained are the good agreement with the 
mechanism, depicted in scheme 2B.2. 
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Scheme 2B.2: Mechanistic pathways for the photodegradation of QTP in presence of 
DCB under anaerobic condition. 
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Photophysical Properties 
Effect of the concentration ofphotoproducts on the absorption intensity 
Fig. 2.3a-b represents the absorption spectra of the photoproduct 7 and 8 on 
continuous increasing the molar concentration in the ranges of 200-300 nm. The 
spectra of the photoproducts are different from the parent drug molecule, suggested 
the formation of new photoproducts. From the figure, it is clear that the peak intensity 
of the photoproducts continuously increases with increasing the concentration of 
photoproducts, there is no shift in the absorption maxima and the nature of the 
absorption profile remains almost constant shown in Fig. 2.3a-b. 
Effect of concentration of photoproducts on fluorescence intensity 
The fluorescence spectra of the molecules deal with the excited state of molecule. The 
spectra of the photoproducts were carried out with continuous increasing the molar 
concentrations of compound at a fixed excited wavelength of the molecule in the 
range of 300-450 nm. From the figure, it is clear that the peak intensity of 
photoproducts increases by about 10 times on increasing the concentration of the 
photoproduct. The photoproducts 7 and 8 were excited at different wavelengths 280 
and 246 nm, respectively. The fluorescence intensity vs. wavelength plot of the 
photoproducts is shown in Fig. 2.4a-b. 
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In conclusion, the drug Quetiapine (6) undergoes photochemical transformation in the 
presence of both electron donor molecule (DMA) and electron acceptor molecule 
(DCB) under anaerobic condition in UV light through photoinduced electron transfer 
mechanism. The importance of the photophysical studies is that at higher 
concentration photoproducts, it absorbs a large fraction of light radiation and the 
excited state of molecule may interact with the biological system and the 
photoproducts may undergoes further dissociation in presence of UV light. On the 
basis of obtained results, the electron-transfer plays a significant role in the 
photodegradation of Quetiapine. The involvement of radical ions may account for the 
phototoxic effects, sometime observed, in therapeutic uses of the drug. Therefore, the 
obtain data confirmed that the adequate light protection should be adopted for the 
handling and storage of Quetiapine and it suggested that excessive sunlight should be 
avoided after the drug consumption. 
Page 96 
References 
1. G. Condorelli, L.L Costanzo, G. D. Guidi, S. Giuffrida, S. Sortino, 
Photochem. Photobiol, 1995, 62, 155. 
2. S. Sortino, S. Petralia, R. Darcy, R. Donohueb, A. Mazzaglia, New J. Chem., 
2003, 27, 602. 
3. C. S. Foote, Photochem. Photobiol, 1991, 54, 659. 
4. S. Onoue, Y. Yamauchi, T. Kojima, N. Igarashi, Y. Tsuda, Pharm. Res., 2008, 
25,4. 
5. S. Sortino, J. C. Scaiano, S. Giurida, New J. Chem., 1999, 23, 1159. 
6. S. Sortino, G. Cosa, J. C. Scaiano, New J. Chem., 2000, 24, 159. 
7. S. Caffieria, S. D. Acqua, I. Castagliuolo, P. Brunb, G. Mioloa., J.Pharm. 
Biomed. Anal, 2008, 47, 771. 
8. F. Bosch. M. A. Miranda, G. Carganico, D. Mauleon, J. Photochem. 
Photobiol. 60, 1994, 96-\0\. 
9. C. Garcia, L. Pinero, R. Oyola, R. Aice, photochem. photobiol. 2009; 85 (1), 
160-170. 
10. M. Lu, J. G. Fang, Z. Li Liu, L. M. Wu, Chin. Chem. Lett, 2002,13, 923. 
11. M. A. Miranda, H. Gar, American Chemical Society, Chem. Rev. 1994, 94, 
1063-1089. 
12. B. Quintero, M. A. Miranda, Ars Pharm., 2000, 41, 27. 
13. D. R. Sibley, J. M. Beaulieu and R. R. Gainetdinov, Ameri. Soc. for Pharm., 
2011,63,182-217. 
14. Drummond, P. Mary (1997). Masters thesis, Rhodes University. 
15. C. Garcia, R. Oyola, Lu. E. Pinero, R. Arce, J. SilvaJ. Phys. Chem. A, 2005, 
109,3360-3371. 
Page 97 
16. M. Noboru, K. Masami, S. Kazue, S. Hiroshi; 2006, 7 (12), 1055-1066. 
17. Nif neurosci. Inform. Framework, drug Bank: drugs, Drugbank; 
Triflupromazine(DB00508). www. drugbank.caydrugs/DB00508. 
18. G. Miolo, L. Levorato, F. Gallocchio, S. Caffieri, C. Bastianon, R. Zanoni, and 
E. Reddi. Chem. Res. Toxicol., 2006,19,156-163. 
19. E. Baciocchi, T. D. Giacco, O. Lanzalunga, A. Lapi, D. Raponi, J. Org. 
Chem., 2007, 72, 5912-5915. 
20. A. Jaszczyszyn, K. gsiorowski, P. switek, W. malinka, K. C. Boczula, J. 
Petrus, B. C. Matusewic. Pharma. report, 2012, 64, 16-23. 
21. B. Quintero, M. A. Miranda, Ars Pharm., 2000, 41, 27. 
22. P. O. J. Soberer, J. Phys. Chem. A., 2003,107, 8327. 
23. Y. Yoshimi , S. Hayashi , K. Nishikawa ,Y. Haga, K. Maeda, T. Morita, T. 
Itou, Y. Okada, N. Ichinose, M. Hatanaka, Molecules, 2010,15, 2623. 
24. G.C. Alexander, S.A. Gallagher, A. Mascola, Pharma. Drug. Saf., 2011. 20(2), 
177-184. 
25. B.J. Kinon, D.L. Noordsy, H. L. Seifert, A.H. Gulliver, H. A. Svanum, S. K. 
Walker, J. Clin. Psychopharm. 2006, 26, 453. 
26. R. Andrezina, R.C. Josiassen, R.N. Marcus, D.A. Oren, G. Manos, E. Stock. 
W.H. Carson, T. Iwamoto, Psychopharma. Berl, 2006,188, 281. 
27. S. Miyamoto, G.E, Duncan, C.E. Marx, J.A. Lieberman, Mole. Psychiatry, 
2005,10, 79-104. 
28. H. Y. Meltzer, Z. Li, Y. Kaneda, J. Ichikawa, Prog. Neuro-Psychopharm. 
Biolo. Psychiatry, 2003, 27(7), 1159-1172. 
29. F. Guzman, "Mechanism of action of quetiapine". Psychopharmacology 
Institute. 20 Jan. 2013. 
Page 98 
30. S. Kapur, P. Seeman, J. Amer. Psychiatry, 2001,158(3), 360-369. 
31. Z. R. Dedania, N. R. Sheth, R. R. Dedania, IJPSR, 2013, 4(6), 2406-2414. 
32. S.M. Cheer, A.J. Wagstaff, CNS Drugs, 2004,18, 173. 
33. W. Aman, K. Thoma, Int. J. Pharm., 2002,28, 33. 
34. H.H. Tennesen, Int. J. Pharm., 2001,1,225. 
35. Scientific problems of photosensitivity; R. Dubakiene, M. Kupriene, M. 
Kaunas, 2006, 8,42. 
36. Phototoxic and Photoallergic Reactions; R. A. Palmer, I. R. White, chap. 17. 
37. I. Ahmad, Q. Fasihullah, F.H.M. Vaid, J. Photochem. Photobiol. B, 2006, 
82(1), 21-27. 
38. J.V. Greenhill, M.A. McLelland, G.P. Ellis, J.B., Prog. Med Chem., 1990, 51, 
121-126. 
39. A.C. Boreen, W.A. Arnold, K. McNeill, Aqua. Sci. 2003, 65, 320-341. 
40. S. Singh, M. Bakshi, Pharm. Tech. On-Line India, 2000, 24,1-14. 
41. R.K. Trivedi, M.C. Patel, Sci. Pharm., 2011, 97, 79. 
42. P. 0. J. Scherer, J. Phys. Chem. A., 2003,107, 8327. 
43. L. Boilet, G. Buntinx, C. Lefumeux, O. Poizat, J. Photochem. Photobiol. A: 
Chem., 2004,163, 529-536 
44. Y. Yoshimi, S. Hayashi, K. Nishikawa, Y. Haga, K. Maeda, T. Morita, T. Itou, 
Y. Okada, N. Ichinose, M. Hatanaka, Molecules, 2010,15, 2623. 
45. I. R Gould, S. A. Godleski, P. A Zielinski, S. Farid, Canadian J. Chem, 2003, 
81(6), 111-lU. 
Page 99 
